References
- Davies J, Smith DI. Plasmid-determined resistance to antimicrobial agents. Am Rev Microbiol 32: 469, 1978
- Finland M. Emergence of antibiotic resistance in hospitals, 1935–1975. Rev Infect Dis 1: 14, 1979
- Gorbach SL, Thadepalli H, Norsen J. Anaerobic microorganisms in intraabdominal infections. In: Balows A, Dehann RM, Dowell VR, Guze LB, eds. Anaerobic bacteria: Role in disease. Illinois: Thomas Springfield, p. 399, 1974
- Jules K, Neu HC. Antibacterial activity and beta-lactamase stability of temocillin. Antimicrob Agents Chemother 22: 453, 1982
- Kahan FM, Kropp H, Sundelof G, Birnbaum J. Thienamycin: Development of imipenem–cilastatin. J Antimicrob Chemother 12 ( Suppl D): 1, 1983
- Neu HC, Fu KP. Clavulanic acid, a novel inhibitor of beta-lactamases. Antimicrob Agents Chemother 14: 650, 1978
- Neu HC. The in vitro activity, human pharmacology and clinical effectiveness of new beta-lactam antibiotics. Ann Rev Pharmacol Toxicol 22: 599, 1982
- Neu HC, Labthavikul P. Comparative in vitro activity of N-formimidoyl thienamycin against Gram-positive and Gram-negative aerobic and anaerobic species and its beta-lactamase stability. Antimicrob Agents Chemother 21: 180, 1982
- Neu HC, Labthavikul P. Antibacterial activity of an oral penem SCH29482. J Antimicrob Chemother 9 ( Suppl C): 49, 1982
- Neu HC. The emergence of bacterial resistance and its influence on empiric therapy. Rev Infect Dis 5 ( Suppl): 9, 1983
- Neu HC. Clinical perspectives on imipenem. J Antimicrob Chemother 12 ( Suppl D): 149, 1983
- Neu HC. Beta-lactamase inhibitory activity of iodopenicillanate and bromopenicillanate. Antimicrob Agents Chemother 23: 63, 1983
- Neu HC. Structure-activity relations of beta-lactam compounds and in vitro activity against common bacteria. Rev Infect Dis 5 ( Suppl): 319, 1983
- Scully BE, Jules K, Neu NC. In vitro activity and beta-lactamase stability of cefodizine, an aminothiazolyl iminomethoxy cephalosporin. Antimicrob Agents Chemother 23: 907, 1983
- Scully B, Neu HC. Aztreonam therapy of critically ill patients. Proc 13 Internatl Cong Chemother S461 part 15: 37, 1983
- Sykes RB, Cimarusti CM, Bonner DP, Bush K, Floyd DM, Georgopapadakou NH, Koster WH, Liu WC, Parker WL, Principe PA, Rathnum ML, Slusarchyk WA, Trejo WH, Wells JS. Monocyclic beta-lactam antibiotics produced by bacteria. Nature 291: 489, 1981
- Wise R, Andrews JM, Danks G. Comparison of in vitro activity of FCE 22101, a new penem with those of other beta-lactam antibiotics. Antimicrob Agents Chemother 24: 909, 1983
References
- Burman LG, Park JT. Change in the composition of Escherichia coli murein as it ages during exponential growth. J Bact 155: 447, 1983
- Charlier P, Dideberg O, Dive G, Dusart J, Frère JM, Ghuysen JM, Joris B, Lamotte-Bresseur J, Leyh-Bouille M, Nguyen-Distèche M. The active sites of the d-alanyl-d-alanine-cleaving peptidases. In: Hakenbeck R, Höltje JV, Labischinski H, eds. The target penicillin. The murein sacculus of bacterial cell walls. Architecture and growth. International FEMS Symposium, March 1983, Berlin (West). Berlin: W de Gruyter and Co, 1983
- Charlier P, Dideberg O, Jamoulle JC, Frère JM, Ghuysen JM, Dive G, Lamotte-Brasseur J. Active-site directed inactivators of the Zn2+ d-alanyl-d-alanine-cleaving carboxypeptidase of Streptomyces albus G. Biochim J 219: 763, 1984
- Dideberg O, Charlier P, Dive G, Joris B, Frère JM, Ghuysen JM. Structure at 2.5 Å resolution of a Zn++-containing d-alanyl-d-alanine-cleaving carboxypeptidase. Nature 299: 469, 1982
- Dusart J, Marquet A, Ghuysen JM, Frère JM, Moreno R, Leyh-Bouille M, Johnson K, Lucchi C, Perkins HR, Nieto M. DD-carboxypeptidase-transpeptidase and killing site of β-lactam antibiotics in Streptomyces strains R39, R61 and K11. Antimicrob Ag Chemother 3: 181, 1973
- Frère JM, Reynolds PE, Moreno R, Perkins HR. Binding of β-lactam antibiotics to the exocellular DD-carboxypeptidase-transpeptidase of Streptomyces R39. Biochem J 143: 241, 1974
- Frère JM, Ghuysen JM, Iwatsubo M. Kinetics of interaction between the exocellular DD-carboxypeptidase-transpeptidase from Streptomyces R61 and β-lactam antibiotics. A choice of models. Eur J Biochem 57: 343, 1975
- Frère JM, Kelly JA, Klein D, Ghuysen JM, Claes P, Vanderhaeghe H. Δ2- and Δ3-cephalosporins, penicillanate and 6-unsubstituted penems. Intrinsic reactivity and interaction with β-lactamases and d-alanyl-d-alanine-cleaving serine peptidase. Biochem J 203: 223, 1982
- Ghuysen JM, Leyh-Bouille M, Frère JM, Dusart J, Marquet A, Perkins HR, Nieto M. The penicillin receptor in Streptomyces. Ann NY Acad Sci 235: 236, 1974
- Ghuysen JM. Biosynthesis and assembly of bacterial cell walls. In: Poste G, Nicolson GL, eds. The synthesis, assembly and turnover of cell surface components. North-Holland Publishing Co, 1977
- Ghuysen JM, Frère JM, Leyh-Bouille M, Coyette J, Dusart J, Nguyen-Distèche M. Use of model enzymes in the determination of the mode of action of penicillins and Δ3-cephalosporins. Ann Rev Biochem 48: 73, 1979
- Ghuysen JM, Frère JM, Leyh-Bouille M, Dideberg O, Lamotte-Brasseur J, Perkins HR, De Coen JL. Penicillins and Δ3-cephalosporins as inhibitors and mechanism-based inactivators of d-alanyl-d-Ala peptidases. In: Burgen ASV, and Roberts GCK, eds. Topics in molecular pharmacology. Elsevier/North-Holland Biomedical Press, 63, 1981
- Joris B, Van Beeumen J, Casagrande F, Gerday C, Frère JM, Ghuysen JM. The complete amino acid sequence of the Zn++-containing d-alanyl-d-alanine-cleaving carboxypeptidase of Streptomyces albus G. Eur J Biochem 130: 53, 1983
- Kelly JA, Frère JM, Klein D, Ghuysen JM. Interaction between non-classical β-lactam compounds and the Zn++ G and serine R61 and R39 d-alanyl-d-alanine peptidases. Biochem J 199: 19, 1981
- Kelly JA, Moews PC, Knox JR, Frère JM, Ghuysen JM. Structure of a penicillin target enzyme and location of the antibiotic binding site. Science 218: 479, 1982
- Kelly JA. X-ray structure of a penicillin target enzyme. In: Hakenbeck R, Höltje JV, Labischinski H, eds. The target of penicillin. The murein sacculus of bacterial cell walls. Architecture and growth. Berlin (West). Berlin: W de Gruyter and Co, 387, 1983
- Labischinski H, Giesbrecht P, Fischer E, Barnickel G, Bradaczek H, Frère JM, Houssier C, Charlier P, Dideberg O, Ghuysen JM. Study of the Zn+-containing DD-carboxypeptidase of Streptomyces albus G by small angle X-ray scattering in solution. Eur J Biochem 138: 83, 1984
- Lamotte-Brasseur J, Dive G, Ghuysen JM. On the structural analogy between d-alanyl-d-alanine terminated peptides and β-lactam antibiotics. Eur J Med Chem, 1984 (in press)
- Laurent G, Durant F, Frère JM, Klein D, Ghuysen JM. Des-, syn- and anti-oxyimino Δ3-cephalosporins. Intrinsic reactivity and reaction with RTEM-2 serine β-lactamase and d-alanyl-d-alanine-cleaving serine and Zn-containing peptidases. Biochem J 218: 953, 1984
- Mirelman D. Assembly of wall peptidoglycan polymers. In: Salton MRJ, Shockman GD, eds. β-penicillin-binding protein of Streptomyces strain K15 in the form of a penicillin-sensitive d-67, 1981
- Neuhaus FC, Hammes WP. Inhibition of cell wall biosynthesis by analogous of alanine. Pharmac Ther 14: 265, 1981
- Nguyen-Distèche M, Leyh-Bouille M, Ghuysen JM. Isolation of the membrane-bound 26 000-Mr penicillin-binding protein of Streptomyces strain K15 in the form of a penicillin-sensitive d-alanyl-d-alanine-cleaving transpeptidase. Biochem J 207: 109, 1982
- Spratt BG. Penicillin binding proteins and the future of β-lactam antibiotics. J Gen Microbiol 129: 1247, 1983
- Tomioka S, Ishino F, Tamaki S, Sudo A, Nakagawa JL, Matsuhashi M. Enzymatic synthesis of peptidoglycan-crossbridges in E. coli. In: Hakenbeck R, Höltje JV, Labischinski H, eds. The target of penicillin. The murein sacculus of bacterial cell walls. Architecture and growth. Berlin (West). Berlin: W de Gruyter and Co, 505, 1983
- Waxman DJ, Strominger JL. Penicillin binding proteins and the mechanism of action of β-lactam antibiotics. Ann Rev Biochem 52: 825, 1983
- Yocum RR, Amanuma H, O'Brien TA, Waksman DJ, Strominger JL. Penicillin is an active site inhibitor for four genera of bacteria. J Bact 149: 1150, 1982
References
- Aoki H, Sakai H, Kohsaka M, Konomi T, Hosoda J, Kubochi Y, Iguchi E, Imenaka H. Nocardicin A, a new monocyclic β-lactam antibiotic I. Discovery, isolation and characterization. J Antibiot 29: 492, 1976
- Baltzer B, Binderup E, von Daehne W, Godtfredsen WO, Hansen K, Nielsen B, Sörensen H, Vengedal S. Mutual pro-drugs of β-lactam antibiotics and β-lactamase inhibitors. J Antibiotics 33: 1183, 1980
- Brown AG, Butterworth D, Cole M, Hanscomb G, Hood JD, Reading C, Rolinson GN. Naturally occurring β-lactamase inhibitors with antibacterial activity. J Antibiot 29: 668, 1976
- Brown AG, Corbett DF, Eglington AJ, Howarth T. Structures of olivanic acid derivatives MM 4550 and MM 13902; Two new, fused β-lactams isolated from Streptomyces olivaceus. J C S Chem Commun 523, 1977
- Brown AG. New naturally occurring β-lactam antibiotics and related compounds. J Antimicrob Chemother. 7: 15, 1981
- Brown RM, Wise R, Andrews JM. Sch 29482—a novel penem antibiotic; an in vitro comparison of its activity with other β-lactams. J Antimicrob Chemother 9 Suppl C: 17, 1982
- Cama LD, Christensen BG. Total synthesis of β-lactam antibiotics. VII. Total synthesis of (±)-l-oxacephalothin. J Am Chem Soc 96: 7582, 1974
- Fischer J, Belasco JG, Charnas RL, Khosla S, Knowles JR. β-Lactamase inactivation by mechanism-based reagents. Phil Trans R Soc Lond B 289: 309, 1980
- Franceschi G, Foglio M, Alpegieni M, Baltistini C, Bedeschi A, Penone E, Zarini F, Accamone F, Della Brana C, Sanfilippo A. Synthesis and biological properties of sodium (5R, 6S, 8R)-6α-hydroxyethyl-2-carbamoyloxymethyl-2-penem-3-carboxylate (FCE 22101 and its orally absorbed esters FCE 22553 and FCE 22891. J Antibiotics 36: 938, 1983
- Ganguly AK, Girijavallabhan VM, McCombie S, Pinto P, Rizvi R, Jeffrey PD, Lin S. Synthesis of Sch 29482—a novel penem antibiotic. J Antimicrob Chemother 9, Suppl. C: 1, 1982
- Imada A, Kitano K, Kintaka K, Muroi M, Asai M. Sulfazecin and isosulfazecin, novel β-lactam antibiotics of bacterial origin. Nature 289: 590, 1981
- Kahan JS, Kahan FM, Goegelman R, Currie SA, Jackson M, Stapley EO, Miller TW, Miller AK, Hendlin D; Mochales S, Hernandez S, Woodruff HB, Birnbaum J. Thienamycin, a new β-lactam antibiotic I. Discovery, taxonomy, isolation and physical properties. J Antibiot 32: 1, 1979
- Kondo M, Kishimoto S, Ochiai M, Okonogi K, Imada A. In vitro and in vivo evaluation of AMA-1080 (RO 17-2301), a new synthetic sulfazecin-type antibiotic. In: Spitzy KH, Karrer K, eds. Proceedings 13th International Congress of Chemotherapy, 56/1, 1983
- Lund F, Tybring L. 6-Beta-amidinopenicillanic acids—a new group of antibiotics. Nature New Biology 236: 135, 1972
- Nagarajan R, Boeck LD, Gorman M, Hamill RL, Higgens CE, Hoehn MM, Stark WM, Whitney JG. β-Lactam antibiotics from streptomyces. J Am Chem Soc 93: 2308, 1971
- Nordbring F. Review of side-effects of aminopenicillins. Infection 7, Suppl. 5: 5503, 1979
- Phillips I, King A, Shannon K, Warren C. Sch 29482: In vitro antibacterial activity and susceptibility to β-lactamases. J Antimicrob Chemother 9, Suppl. C: 25, 1982
- Ratcliffe RW, Albers-Schönberg G. The chemistry of thienamycin and other carbapenem antibiotics. In: Morin RB, Gorman M, eds. Chemistry and biology of β-lactam antibiotics, New York: Academic Press, 227, 1982
- Slocombe B, Basker MJ, Bently PH, Clayton JP, Cole M, Comber KR, Dixon RA, Edmondson RA, Jackson D, Merrikin DJ, Sutherland R. BRL 17421, a novel β-lactam antibiotic, highly resistant to β-lactamases, giving high and prolonged serum levels in humans. Antimicrob Agents Chemother 20: 38, 1981
- Sykes RB, Cimarusti CM, Bonner DP, Bush K, Floyd DM, Georgopapadakou NH, Koster WH, Liu WC, Parker WL, Principe PA, Rathnum ML, Slusarchyk WA, Trejo WH, Wells JS. Monocyclic β-lactam antibiotics produced by bacteria. Nature 291: 489, 1981
- Sykes R, Bonner DP, Bush K, Georgopapadakou NH, Azthreonam (SQ 26 776), a synthetic monobactam specifically active against aerobic Gram-negative bacteria. Antimicrob Agents Chemother 21: 85, 1982
- Sykes RB, Bonner DP, Cimarusti CM. Monobactams and the development of azthreonam. In: Spitzy KH, Karrer K, eds. Proceedings 13th International Congress of Chemotherapy, Part 15, 15/2, 1983
- Veo K, Fukuoka Y, Hayashi T, Yasuda T, Taki H, Tai M, Watanabe Y, Saikawa I, Mitsuhashi S. In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. Antimicrob Agents Chemother 12: 455, 1977
- Waxman DJ, Strominger JL. β-Lactam antibiotics: Biochemical modes of action. In: Morin RB, Gorman M, eds. Chemistry and biology of β-lactam antibiotics. New York: Academic Press, 209, 1982
- Woodward RB. Recent advances in the chemistry of β-lactam antibiotics. In: Elks J, ed. Recent advances in the chemistry of β-lactam antibiotics. London: Chem Soc Spec Publ No. 28, 167, 1977
References
- Actor P, Uri JV, Zajac, I, Guarini JR, Phillips L, Pitkin DH, Berges DA, Dunn GL, Hoover JRE, Weisbach JA. SK&F 75073, new parenteral broad spectrum cephalosporin with high and prolonged serum levels. Antimicrob Agents Chemother 13: 784, 1978
- Arvidsson AG, Alvan G, Angelin B, Borga O, Nord CE. Ceftriaxone: Renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother 10: 207, 1983
- Barriere SL, Hatheway GJ, Gambertoglio JG, Lin ET, Conte JE, Jr. Pharmacokinetics of cefonicid, a new broad spectrum cephalosporin. Antimicrob Agents Chemother 21: 935, 1982
- Barza M, Melethil S, Berger S, Ernst EC. Comparative pharmacokinetics of cefamandole, cephapirin and cephalothin in healthy subjects and effect of repeated doses. Antimicrob Agents Chemother 10: 421, 1976
- Braun P, Tillotson JR, Wilcox C, Finland M. Cephalexin and cephaloglycin activity in vitro and absorption and urinary excretion of single oral doses in normal young adults. Appl Microbiol 16: 1684, 1968
- Foord RD. Cefuroxime: Human pharmacokinetics. Antimicrob Agents Chemother 9: 741, 1976
- Fukasawa M, Noguchi H, Okuda T, Komatsu T, Yano K. In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity. Antimicrob Agents Chemother 23: 195, 1983
- Granneman GR, Sennello LT, Steinberg FJ, Sonders RC. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects. Antimicrob Agents Chemother 21: 141, 1982
- Granneman GR, Sennello LT, Sonders RC, Wynne B, Thomas EW. Cefsulodin kinetics in healthy subjects after intramuscular and intravenous injections. Clin Pharmacol Therap 31: 95, 1983
- Griffith RS, Black HR. Blood, urine and tissue concentrations of the cephalosporin antibiotics in normal subjects. Postgrad Med J 47 ( Feb. Suppl.): 32, 1971
- Kakeya N, Nishimura K, Yoshima A, Nakamura S, Nishizawa S, Tamaki S, Matsui H, Kawamura T, Kasai M, Tachi T, Kitao K. New orally active cephalosporin esters, KY-101, KY-107, and KY-109. Prog & absts, 23rd ICAAC, Las Vegas, Nevada: Abst 257, 1983
- Kato Y, Sato R, Ishikawa K, Shinohara M, Tomisawa M, Nakayama Z, Konoshita Y, Sato K. Examination of T-1982 in basic and internal medicine. Chemother 30 ( Suppl S-3): 359, 1982
- Kemmerich B, Lode H, Belmega G, Jendroschek T, Borner K, Koeppe P. Comparative pharmacokinetics of cefoperazone, cefotaxime and moxalactam. Antimicrob Agents Chemother 23: 429, 1983
- Lipsky JJ. N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: Possible mechanism for antibiotic-associated hypoprothrombinaemia. Lancet ii:192, 1983
- Luscombe DK, Nicholls PJ, Owens DR, Russell AD. Pharmacokinetics in animals and humans of a new cephalosporin, the sodium salt of 7-cyanoacetylamino cephalosporanic acid. Arzneim Forsch 24: 1478, 1974
- Nagarajan R, Boeck LD, Gorman M, Hamill RL, Higgens CE, Hoehn MM, Stark WM, Whitney JG. β-Lactam antibiotics from streptomyces. J Am Chem Soc 93: 2308, 1971
- Nakagawa K, Koyama M, Nakatsuru N, Yoshinaga K, Matsui H, Ikeda C, Yano K, Noguchi T. Human pharmacokinetics of SM-1652. Prog & absts, 20th ICAAC, New Orleans, Louisiana: Abst 149, 1980
- Nakagawa K, Koyama M, Tachibana A, Komiya M, Kikuchi Y, Yano K. Pharmacokinetics of cefotetan in humans. Antimicrob Agents Chemother 22: 935, 1982
- Nakashima M, Ueno K. Pharmacokinetics and safety of FK027 in healthy volunteers. Prog & absts, 23rd ICAAC, Las Vegas, Nevada: Abst 265A, 1983
- Neu HC, Srinivasan S. Pharmacology of ceftizoxime compared with that of cefamandole. Antimicrob Agents Chemother 20: 366, 1981
- Newton GGF, Abraham EP. Cephalosporin C, a new antibiotic containing sulphur and d-α-aminoadipic acid. Nature (London) 175: 548, 1955
- O'Callaghan CH, Muggleton PW. The formation of metabolites from cephalosporin compounds. Biochem J 89: 304, 1963
- Price KE. Unpublished data.
- Pfeffer M, Jackson A, Ximenes J, Perche de Menezes J. Comparative human oral clinical pharmacology of cefadroxil, cephalexin and cephradine. Antimicrob Agents Chemother 11: 331, 1977
- Pfeffer M, Gaver RC, Van Harken DR. Human pharmacokinetics of a new broad-spectrum cephalosporin antibiotic, ceforanide. J Pharm Sci 69: 398, 1980
- Pfeffer M, Gaver RC, Ximinez, J. Human intravenous pharmacokinetics and absolute oral bioavailability of cefatrizine. Antimicrob Agents Chemother 24: 915, 1983
- Pollock AA, Tee PE, Patel IH, Spicehandler J, Simberkoff MS, Rahal JJ Jr. Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults. Antimicrob Agents Chemother 22: 816, 1982
- Regamey C, Gordon RC, Kirby WMM. Cefazolin vs. cephalothin and cephaloridine. Arch Intern Med 133: 407, 1974
- Sassiver ML, Lewis A. Structure–activity relationships among semisynthetic cephalosporins. I. The first generation compounds. In: Structure–activity relationships among the semisynthetic antibiotics. Perlman D, ed. New York, N.Y.; Academic Press, 149, 1977
- Schrogie JJ, Davies RO, Yeh KC, Rogers D, Holmes GI, Skeggs H, Martin CM. Bioavailability and pharmacokinetics of cefoxitin sodium. J Antimicrob Chemother 4 ( Suppl B): 69, 1978
- Sommers De K, Van Wyk M, Williams PEO, Harding SM. Cefuroxime axetil: Pharmacokinetics and tolerance during repeated dosing in volunteers. Prog & absts, 23rd ICAAC, Las Vegas, Nevada: Abst 720, 1983
- Scrinivasan S, Fu KP, Neu HC. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers. Antimicrob Agents Chemother 19: 302, 1981
- Srinivasan S, Franke EL, Neu HC. Comparative pharmacokinetics of cefoperazone and cefamandole. Antimicrob Agents Chemother 19: 298, 1981
- Tsuchiya K, Kida M, Kondo M, Ono H, Takeuchi M, Nishi T. SCE-963, a new broad-spectrum cephalosporin: In vitro and in vivo antibacterial activities. Antimicrob Agents Chemother 14: 557, 1978
- Uri JV, Parks DB. Disulfiram-like reaction to certain cephalosporins. Therap Drug Monitoring 5: 219, 1983
- Welling PG, Dean S, Selen A, Kendall MJ, Wise R. The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin. Internat J Clin Pharmacol Biopharm 17: 397, 1979
- Wise R, Armstrong GC, Brown RM, Andrews JM. The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers. J Antimicrob Chemother 8 ( Suppl B): 277, 1981
References
- Cafferkey MT, Hone R, Falkiner RF, Keane CT, Pomeroy H. Gentamicin and methicillin resistant Staphylococcus aureus in Dublin hospitals: clinical and laboratory studies. J Med Microbiol. In press.
- Eickhoff TC. Nosocomial infections. N Engl J Med 306: 1545, 1982
- Giamarellou H, Papapetropoulou M, Daikos GK. Methicillin-resistant Staphylococcus aureus infections during 1978–1979: clinical and bacteriologic observations. J Antimicrob Chemother 7: 649, 1981
- Jevons MP. “Celbenin”-resistant staphylococci. Br Med J 1: 124, 1961
- Knox R. “Celbenin”-resistant staphylococci. Br Med J 1: 126, 1961
- Lacey RW. Antibiotic resistance plasmids of Staphylococcus aureus and their clinical importance. Bact Rev 39: 1, 1975
- Lacey RW. Evidence for two mechanisms of plasmid transfer in mixed cultures of Staphylococcus aureus. J Gen Microbiol 119: 423, 1980
- Lacey RW. Antibiotic resistance in Staphylococcus aureus and streptococci. Br Med Bull 40: 77, 1984
- Lacey RW, Lewis EL. Further evolution of a strain of Staphylococcus aureus in vivo: evidence for significant inactivation of flucloxacillin by penicillinase. J Med Microbiol 8: 337, 1975
- Lacey RW, Lord VL. Transfer of gentamicin resistance between cultures of Staphylococcus aureus in nutrient broth, serum and urine. J Med Microbiol 13: 411, 1980
- Lacey RW, Stokes A. Susceptibility of the “penicillin-resistant” penicillins and cephalosporins to penicillinase of Staphylococcus aureus. J Clin Pathol 30: 35, 1977
- Lyon BR, May JW, Marshall JH, Skurray RA. Plasmid-mediated antibiotic resistance in methicillin-resistant Staphylococcus aureus. Med J Aust 1: 468, 1982
- Noble WC. Variation in the prevalence of antibiotic resistance of Staphylococcus aureus from human skin and nares. J Gen Microbiol 98: 125, 1977
- Noble WC. Selection of penicillin-resistant staphylococci on murine skin. Br J Exp Pathol. In press.
- Novick RP. Analysis by transduction of mutations affecting penicillinase formation in Staphylococcus aureus. J Gen Microbiol 33: 121, 1963
- Pavillard R. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aeurus in major Victorian hospitals. Med J Aust 1: 458, 1982
- Phillips S, Novick RP. Tn554—a site specific represses—controlled transposon in Staphylococcus aureus. Nature 278: 476, 1979
- Richmond MH. Wild-type variants of exopenicillinase from Staphylococcus aureus. Biochem J 94: 584, 1965
- Rosdahl VT. Naturally occurring constitutive beta-lactamase of movel serotype in Staphylococcus aureus. J Gen Microbiol 77: 229, 1973
- Sjöström J-E, Lofdahl S, Philipson L. Transformation of Staphylococcus aureus by heterologous plasmids. Plasmid 2: 529, 1979
- Stewart GC, Rosenblum ED. Genetic behaviour of the methicillin resistance determinant in Staphylococcus aureus. J Bacteriol 144: 1200, 1980
References
- Aldridge KE, Sanders CV, Lewis AC, Marier RL. Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J Med Microbiol 16: 75, 1983
- Anderson JD, Sykes RB. Characterization of a beta-lactamase obtained from a strain of Bacteroides fragilis resistant to beta-lactam antibiotics. J Med Microbiol 6: 201, 1973
- Blandino G, Olsson-Liljequist B, Nord CE. Characterization of beta-lactamases from Clostridium butyricum. Chemioterapia 2: 95, 1983
- Botta GA, Privitera G, Menozzi MG. Penicillin-binding proteins in Bacteroides fragilis and their affinities for several new cephalosporins. J Antimicrob Chemother 11: 325, 1983
- Britz ML, Wilkinson RG. Purification and properties of beta-lactamase from Bacteroides fragilis. Antimicrob Agents Chemother 13: 373, 1978
- Butler T, Tally FP, Gorbach SL, Malamy M. Transferable ampicillin resistance in Bacteroides fragilis. Clin Res 28: 365, 1980
- Cuchural GJ, Tally FP, Jacobus NV, Marsh PK, Mayhew JW. Cefoxitin inactivation by Bacteroides fragilis. Antimicrob Agents Chemother 24: 936, 1983
- Darland G, Birnbaum J. Cefoxitin resistance to beta-lactamase: A major factor for susceptibility of Bacteroides fragilis to the antibiotic. Antimicrob Agents Chemother 11: 725, 1977
- Del Bene VE, Farrar WE Jr. Cephalosporinase activity in Bacteroides fragilis. Antimicrob Agents Chemother 3: 369, 1973
- Dornbusch K, Nord CE, Olsson-Liljequist B. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis. Scand J Infect Dis 19: 17, 1979
- Dornbusch K, Olsson-Liljequist B, Nord CE. Antimicrobial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. J Antimicrob Chemother 6: 207, 1980
- Edson RS, Rosenblatt JE, Lee DT, McVey III EC. Recent experience with antimicrobial susceptibility of anaerobic bacteria. Increasing resistance to penicillin. Mayo Clin Proc 57: 737, 1982
- Ensminger PW, Counter FT, Thomas LJ, Lubbehusen PP. Susceptibility, resistance development and synergy of antimicrobial combinations against Clostridium difficile. Current Microbiol 7: 59, 1982
- Gabay EL, Sutter VL, Finegold SM. Rapid beta-lactamase testing in Bacteroides. J Antimicrob Chemother 8: 413, 1981
- Garrod LP. Sensitivity of four species of Bacteroides to antibiotics. Br Med J ii:1529, 1955
- Georgopapadakou NH, Smith SA, Sykes RB. Penicillin-binding proteins in Bacteroides fragilis. J Antibiotics 34: 907, 1983
- Hart CA, Barr K, Makin T, Brown P, Cooke RW. Characteristics of a beta-lactamase produced by Clostridium butyricum. J Antimicrob Chemother 10: 31, 1982
- Leung T, Williams JD. Beta-lactamases of subspecies of Bacteroides fragilis. J Antimicrob Chemother 4: 47, 1978
- Magot M. Some properties of the Clostridium butyricum group beta-lactamase. J Gen Microbiol 127: 113, 1981
- Marrie TJ, Haldane EV, Swantee CA, Kerr EA. Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin. Antimicrob Agents Chemother 19: 51, 1981
- Maskell JP, Nasu M, Williams JD. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid. J Antimicrob Chemother 13: 23, 1984
- Matthew M. Plasmid mediated beta-lactamases of Gram-negative bacteria: Properties and distribution. J Antimicrob Chemother 5: 349, 1979
- Montgomery K, Raymundo L, Drew WL. Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria. J Clin Microbiol 9: 205, 1979
- Murphy TF, Barza M, Park JT. Penicillin-binding proteins in Clostridium perfringens. Antimicrob Agents Chemother 20: 809, 1981
- Murray PR, Rosenblatt JE. Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus. Antimicrob Agents Chemother 11: 605, 1977
- Nord CE, Olsson-Liljequist B. Resistance to beta-lactam antibiotics in Bacteroides species. J Antimicrob Chemother 8: 33, 1981
- Nord CE, Heimdahl A, Lundberg C. Anaerobic infections in the upper respiratory tract. Drugs Clin Exptl Res 3: 155, 1984
- Olsson B, Nord CE, Wadström T. Formation of beta-lactamase in Bacteroides fragilis. Cellbound and extracellular activity. Antimicrob Agents Chemother 9: 727, 1976
- Olsson B, Dornbusch K, Nord CE. Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis. Med Microbiol Immunol 163: 183, 1977
- Olsson B, Dornbusch K, Nord CE. Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis. Antimicrob Agents Chemother 15: 263, 1979
- Olsson-Liljequist B, Dornbusch K, Nord CE. Characterization of three different beta-lactamases from the Bacteroides fragilis group. Antimicrob Agents Chemother 18: 220, 1980
- Ratschian A, Bubes GR, Booth SM. Transferable resistance to cefoxitin in Bacteroides thetaio-taomicron. Antimicrob Agents Chemother 22: 701, 1982
- Sato K, Inoue M, Mitsuhashi S. Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins. Antimicrob Agents Chemother 17: 736, 1980
- Sato K, Matsura Y, Inoue M, Mitsuhashi S. Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother 22: 579, 1982
- Sherrill JM, McCarthy LR. Cephalosporinase activity within the Bacteroides fragilis group and in strains of Bacteroides melaninogenicus and Bacteroides oralis. Current Chemother 1: 758, 1979
- Skarin A, Holst E, Mårdh PA. Antimicrobial susceptibility of comma-shaped bacteria isolated from the vagina. Scand J Infect Dis 40: 81, 1983
- Snydman DR, Tally FP, Knuppel R, Landrigan J, Gorbach SL, Bartlett JG. Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities. J Antimicrob Chemother 6: 519, 1980
- Tajima M, Sawa K, Watanabe K, Ueno K. The beta-lactamases of genus Bacteroides. J Antibiotics 34: 423, 1983
- Tally FP, O'Keefe JP, Sullivan NM, Gorbach SL. Inactivation of cephalosporins by Bacteroides. Antimicrob Agents Chemother 16: 565, 1979
- Tally FP, Cuchural GJ, Jacobus NV, Gorbach SL, Aldridge KE, Cleany TJ, Finegold SM, Hill GB, Jannini PB, McCloskey RV, O'Keefe JP, Pierson CL. Susceptibility of the Bacteroides fragilis group in the United States 1981. Antimicrob Agents Chemother 23: 536, 1983
- Timewell R, Taylor E, Phillips I. The beta-lactamases of Bacteroides species. J Antimicrob Chemother 7: 137, 1981
- Timewell R, Phillips I, Söderholm J, Nord CE. Isoelectric focusing of Bacteroides melaninogenicus group beta-lactamases. Antimicrob Agents Chemother 19: 700, 1981
- Weinrich AG, Del Bene VE. Beta-lactamase activity in anaerobic bacteria. Antimicrob Agents Chemother 10: 106, 1976
- Williamson R. Resistance of Clostridium perfringens to beta-lactam antibiotics mediated by a decreased affinity of a single essential penicillin-binding protein. J Gen Microbiol 129: 2339, 1983
- Yotsuji A, Minami S, Inoue M, Mitsuhashi S. Properties of novel beta-lactamase produced by Bacteroides fragilis. Antimicrob Agents Chemother 24: 925, 1983
References
- Actor P, Pitkin DH, Lucyszyn G, Weisbach JA, Bran JL. Cefatrizine (SKF 60771), a new oral cephalosporin serum levels and urinary recovery in humans after oral or intramuscular administration. Comparative study with cephalexin and cephazolin. Antimicrob Agents Chemother 9: 800, 1976
- Bergan T. Pharmacokinetics of mezlocillin in healthy volunteers. Antimicrob Agents Chemother 14: 801, 1978
- Bergan T. Penicillins. Antibiot Chemother 25: 1, 1978
- Bergan T. Pharmacokinetics of a new cephalosporin, CGP 9000 (cefroxadine), in healthy volunteers. Chemotherapy 26: 225, 1980
- Bergan T. Propulsive load administration. Singapore Med J 24: 82, 1983
- Bergan T. Review of the pharmacokinetics of mezlocillin. J Antimicrob Chemother 11 Suppl C: 1, 1983
- Bergan T. Tissue pharmacokinetics of ceftriaxone. In: Proc 13th Int Congr Chemother, vol. SS 8.6/1, part 46, pp. 28/5–28/8. Wien, 1983
- Bergan T, Brodwall EK, Larsen EW. Relationship between pharmacokinetics and bioavailability of cefroxadine (CGP 9000) and renal function. Chemotherapy 29: 163, 1983
- Bergan T, Engeset A, Olszewski W, Sjövall J. Distribution to human peripheral lymph of amoxycillin and ampicillin from the oral prodrug bacampicillin. J Antimicrob Chemother 12: 497, 1983
- Bergan T, Engeset A, Olszewski W. Temocillin in peripheral lymph. J Antimicrob Chemother 12: 59, 1983
- Bergan T, Kalager T, Hellum K B, Solberg CO. Penetration of cefotaxime and desacetylcefotaxime to skin blister fluid. J Antimicrob Chemother 10: 193, 1982
- Bergan T, Solberg R. Assay of cefotaxime by high-pressure-liquid chromatography. Chemotherapy 27: 155, 1981
- Bergan T, Thorsteinsson SB, Steingrimsson O. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin. Chemotherapy 28: 160, 1982
- Bergan T, Versland I. Experience with the teflon chamber model. In: Proc 13th Int Congr Chemother, vol. SS 8.6/1, part 46, pp. 46/6–46/10. Wien, 1983
- Bergan T, Williams JD. Dose dependence of piperacillin pharmacokinetics. Chemotherapy 28: 153, 1982
- Brogden RN, Carmine A, Heel RC, Morley PA, Speight TM, Avery GS. Amoxicillin/clavulanic acid: A review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs 22: 337, 1981
- Brogard JM, Comte F, Pinget M. Pharmacokinetics of cephalosporin antibiotics. Antibiot Chemother 25: 123, 1978
- Brogard JM, Comte F. Pharmacokinetics of the new cephalosporins. Antibiot Chemother 31: 145, 1982
- Brown RM, Wise R, Andrews JM. Temocillin, in vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers. J Antimicrob Chemother 10: 295, 1982
- Findlay CD, Brown RM, Allcock JE, Lowe PA, Wise R. A study of the relationship between dose and pharmacokinetics of ceftriaxone. J Antimicrob Chemother 9: 57, 1982
- Gural R, Lin C, Chung M, Oden E, Digiore C. Oral absorption and tolerance in man, of a new penem antibiotic, SCH 29482. J Antimicrob Chemother 9 Suppl C: 239, 1982
- Harding SM, Williams PEO, Ayrton J. Pharmacology of cefuroxime as the l-acetoxyethyl ester in volunteers. Antimicrob Agents Chemother 25: 78, 1984
- Kahan FM, Kropp H, Sundelof JG, Birnbaum J. Thienamycin: Development of imipenem-cilastin. J Antimicrob Chemother 12 Suppl D: 1, 1983
- Leroy A, Humbert G, Fillastre J-P, Borsa F, Godin M. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function. J Antimicrob Chemother 12: 47, 1983
- Leroy A, Humbert G, Godin M, Fillastre JP. Pharmacokinetics of cefadroxil in patients with impaired renal function. J Antimicrob Chemother 10 Suppl B: 39, 1982
- Lode H, Elvers A, Koeppe P, Borner K. Comparative pharmacokinetics of apalcillin and piperacillin. Antimicrob Agents Chemother 25: 105, 1984
- Naber K, Adam D, Kees F, Lintz W, Grobecker H. Cefmenoxim: Pharmakokinetik bei Jüngeren Probanden gegenüber älteren Patienten und Gewebekonzentrationen im Urogenitaltrakt. Fortschr Antimicrob Antineoplast Chemother 2: 297, 1983
- Norrby SR, Alestig K, Ferber F, Huber JL, Jones KH, Kahan FM, Meisinger MAP, Rogers JD. Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK 0787) in humans. Antimicrob Agents Chemother 23: 293, 1983
- Norrby SR, Björnegprd B, Ferber F, Jones KH. Pharmacokinetics of imipenem in healthy volunteers. J Antimicrob Chemother 12 Suppl D: 109, 1983
- O'Callaghan CH. Description and classification of the newer cephalosporins and their relationships with the established compounds. J Antimicrob Chemother 5: 635, 1979
- Otten H, Plempel M, Siegenthaler W. Antibiotika-Fibel, 4th ed, pp. 170–319. Stuttgart: Geroge Thieme Verlag, 1975
- Patel IH, Miller K, Weinfeld R, Spicehandler J. Multiple intravenous dose pharmacokinetics of ceftriaxone in man. Chemotherapy 27 Suppl 1: 47, 1981
- Quintilliani R, Nightingale CH. Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans. J Antimicrob Chemother 10 Suppl C: 99, 1982
- Riess W, Meyer-Brunot H-G, Brechbühler S. Pharmakokinetik oraler Cephalosporine. Fortschr Antimikrob Antineoplast Chemother 1: 115, 1982
- Ripa S, Prenna M, Pannelli F, Ghezzi A. BL-S 640 (cefatrizine): Human pharmacokineptics. Drugs Exptl Clin Res 7: 91, 1981
- Santella PJ, Henness D. A review of the bioavailability of cefadroxil. J Antimicrob Chemother 10 Suppl B: 17, 1982
- Schrogie JJ, Davies RO, Yeh KC, Rogers D, Holmes GI, Skeggs H, Martin CM. Bioavailability and pharmacokinetics of cefoxitin sodium. J Antimicrob Chemother 4 Suppl B: 69, 1978
- Sjövall J. Dose dependence in human absorption of aminopenicillins. Infection 7 Suppl 5: S458, 1979
- Sjövall J, Magni L, Bergan T. Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin. Antimicrob Agents Chemother 13: 90, 1978
- Stöckel K, McNamara PJ, Brandt R, Plozza-Nottebrock H, Ziegler WH. Effect of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther 29: 650, 1981
- Stöckel K. Pharmakokinetik parenteraler Cephalosporine in Prüfphase III. Fortschr Antimicrob Antineoplast Chemother 1: 105, 1982
- Swabb EA, Leitz MA, Pilkiewicz FG, Sugerman AA. Pharmacokinetics of the monobactam SQ 26 776 after single intravenous doses in healthy subjects. J Antimicrob Chemother 8 Suppl E: 131, 1981
- Walstad RA, Hellum KB, Blika S, Dale LG, Fredriksen T, Myhre KI, Spencer GR. Pharmacokinetics and tissue penetration of ceftazidime: Studies on lymph, aqueous humour, akin blister, cerebrospinal and pleural fluid. J Antimicrob Chemother 12 Suppl A: 275, 1983
- Wick WE, Wright WE, Kuder HV. Cephaloglycin and its biologically active metabolite desacetyl-cephaloglycin. Appl Microbiol 21: 426, 1971
- Yates RA, Adam HK, Donnelly RJ, Houghton HL, Charlesworth EA, Laws EA. Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers. J Antimicrob Chemother 11 Suppl A: 185, 1983
References
- Amoury RA, Bowman FO, Malm JR. Endocarditis associated with intracardiac prosthesis: Diagnosis, management and prophylaxis. J Thorac Cardiovasc Surg 51: 36, 1966
- Andrassy K, Koderisch J, Ritz E. Influenze of cefotaxime, cefoperazone, and lamoxactam on hemostasis. 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Miami 1982
- Anon. Antimicrobials and haemostasis. Lancet 1: 510, 1983
- Bruch K. Hypoprothrombinaemia and cephalosporins. Lancet 1: 535, 1983
- Cherubin CE, Corrado ML, Nau SR, Gombert ME, Landesman S, Humbert G. Treatment of Gram-negative bacillary meningitis: Role of the new cephalosporin antibiotics. Rev Infect Dis 4: 453, 1982
- Cunha BA, Gossling HR, Pasternak HS, Nightingale CH, Quintiliani R. The penetration of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg 59-A: 856, 1977
- Miller KW, Chan KKH, McCoy HG. Effects of cardiopulmonary bypass on cefazolin disposition. Clin Pharmacol Ther 27: 550, 1980
- Neu HC. The in-vitro activity, human pharmacology and clinical effectiveness of new beta-lactam antibiotics. Ann Rev Pharmacol Toxicol 22: 599, 1982
- Quintiliani R, Nightingale CH. Cefazolin. Ann Int Med 89: 650, 1978
- Platt R, Ehrlich SL, Afarian J, O'Brien TF, Pennington JE, Kass EH. Moxalactam therapy of infections caused by cephalothin-resistant bacteria: Influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy. Antimicrob Agents Chemother 20: 351, 1981
- Sanders CC, Sanders WE Jr. Emergence of resistance during therapy with the newer beta-lactam antibiotics: Role of inducible beta-lactamase and implications for the future. Reviews Infect Dis 5: 639, 1983
- Sande MA. Antibiotic therapy of bacterial meningitis. Lessons we have learned. Am J Med 71: 507, 1981
- Tally FP, McGowan K, Kellum JM, Gorbach SL, O'Donnel TF. A randomized comparison of cefoxitin with and without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg 193: 318, 1981
- Weitekamp MR, Aber RC. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA 249: 69, 1983
References
- Abrams B, Sklaver A, Hoffman T, Greenman R. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med 90: 789, 1979
- Acar JF, Courvalin P, Chabbert YA. Methicillin-resistant Staphylococcemia; bacteriologic failure of treatment with cephalosporins. In: Hobby GL, ed. Antimicrobial agents and chemotherapy 1970. Bethesda: American Society for Microbiology, 280, 1971
- AHA Committee Report. Treatment of infective endocarditis due to viridans streptococci. Circulation 63: 730A, 1981
- Apicella MA, Perkins RA, Saslaw S. Treatment of bacterial endocarditis with cephalosporin derivatives in penicillin-allergic patients. N Engl J Med 274: 1002, 1966
- Aubertin J, Merlet M, Legendre P, Issanchou AM, Lacut JY, Leng B. Traitement des endocardites bactériennes par l'amoxicilline orale et la gentamicine intramusculaire. Nouv Presse Med 6: 2133, 1977
- Baker CN, Thornsberry C, Facklam RR. Synergism, killing kinetics and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother 19: 716, 1981
- Bayer AS, Chow AW, Guze LB. Listeria monocytogenes endocarditis. Report of a case and review of the literature. Am J Med Sci 273: 319, 1977
- Bayer AS, Morrison JO, Kim KS. Experimental group B streptococcal endocarditis treated with penicillin G versus ceftizoxime. Chemotherapy 29: 352, 1983
- Blair DC, Martin DB. Beta-hemolytic streptococcal endocarditis: Predominance of non-group A organisms. Am J Med Sci 276: 269, 1978
- Bolivar R, Fainstein V, Elting L, Bodey GP. Cefoperazone for the treatment of infections in patients with cancer. Rev Infect Dis 5 ( Suppl): S181, 1983
- Bryant RE, Alford RH. Unsuccessful treatment of staphylococcal endocarditis with cefazolin. JAMA 237: 569, 1977
- Burgess HA, Evans RJ. Failure of cephaloridine in a case of staphylococcal endocarditis. Br Med J 2: 1244, 1966
- Carey RB, Brause BD, Roberts RB. Antimicrobial therapy of Vitamin B6 dependent streptococcal endocarditis. Ann Intern Med 87: 150, 1977
- Cohen PS, Maguire JH, Weinstein L. Infective endocarditis caused by Gram-negative bacteria. A review of literature, 1945–1977. Prog Cardiovasc Dis 22: 205, 1980
- Cooper RH, Savitch CB, Joseph WP, Mills J. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis. Antimicrob Agents Chemother 19: 256, 1981
- Coppens L, Hanson B, Klastersky J. Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin. Antimicrob Agents Chemother 23: 36, 1983
- DeCarvalho EM, Martinelli R, DeOliveira MMG, Rocha H. Cefamandole treatment of Salmonella bacteremia. Antimicrob Agents Chemother 21: 334, 1982
- Durack DT. Review of early experience in treatment of bacterial endocarditis, 1940–1955. In: Bisno AI, ed. Treatment of infective endocarditis. New York: Grune & Stratton, 1, 1981
- Eliopoulos GM, Moellering RC Jr. Azlocillin, mezlocillin and piperacillin. New broad spectrum penicillins. Ann Intern Med 97: 755, 1982
- Ellner JJ, Rosenthal MS, Lerner PI, McHenry MC. Infective endocarditis caused by slow growing, fastidious, Gram-negative bacteria. Medicine (Baltimore) 58: 145, 1979
- Emerson AM, Perinpanayagam RM, Barnado DE. Haemophilus endocarditis. Postgrad Med J 57: 117, 1981
- EORTC International Antimicrobial Therapy Project Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137: 14, 1978
- Epstein JS, Hasselquist SM, Simon GL. Efficacy of ceftriaxone in serious bacterial infections. Antimicrob Agents Chemother 21: 402, 1982
- Gentry LO, Martin MD, Wood BA, Lea AS. Clinical studies of bacteremia, skin and soft tissue, and bone and joint infections. In: Moellering RC Jr, ed. The clinical significance of the newer beta-lactam antibiotics: Focus on cefuroxime. New York: AIDS Press, 75, 1983
- Giamarellou H, Papapetropoulou M, Daikos GK. “Methicillin-resistant” Staphylococcus aureus infections during 1978–1979: clinical and bacteriologic observations. J Antimicrob Chemother 7: 649, 1981
- Karakusis PH, Feczko JM, Goodman LJ, Hanson DM, Harris AA, Levin S, Trenholme GM. Clinical efficacy of cefotaxime in serious infections. Antimicrob Agents Chemother 21: 119, 1982
- Karchmer AW, Moellering RC Jr, Maki DG, Swartz MN. Single antibiotic therapy for streptococcal endocarditis. JAMA 241: 1801, 1979
- Korzeniowski O, Sande MA, The National Collaborative Endocarditis Study Group. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in non-addicts. A prospective study. Ann Intern Med 97: 496, 1982
- Landesman SH, Corrado ML, Tillotson JR, Cleri D, Gombert ME. Cefamandole in Staphylococcus aureus endocarditis. Abst. 279, Program and abstracts of 20th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans. American Society for Microbiology, Washington DC, 1980
- Lerner PI, Gopalakrishna KV, Wolinsky E, McHenry MC, Tan JS, Rosenthal M. Group B streptococcus (S. agalactiae) bacteremia in adults. Analysis of 32 cases and review of the literature. Medicine (Baltimore) 56: 457, 1977
- Limson BM, Guanlao RF, Depakakibo LZ. Piperacillin in the treatment of bacteremia and bacterial endocarditis. In: Nelson ID, Grassi C, eds. Current Chemotherapy and Infectious Disease. Washington DC: American Society for Microbiology, 279, 1980
- Livingston WK, Elliott AM, Dismukes WE, Avent CK, Cobb CG. Clinical evaluation of moxalactam. Antimicrob Agents Chemother 20: 88, 1981
- Malacoff RF, Frank E, Andriole VT. Streptococcal endocarditis (Non-enterococcal, non-group A). Single vs. combination therapy. JAMA 241: 1807, 1979
- Mandell GL, Kaye, D, Levison ME, Hook EW. Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital—Cornell Medical Center. Arch Intern Med 125: 258, 1970
- Marier RL, Fargo S, Saunders CV, Williams W, Derks F, Janney A, Aldridge K. Moxalactam in the therapy of serious infections. Antimicrob Agents Chemother 21: 650, 1982
- Masur H, Murray HW, Roberts RB. Nafcillin therapy for Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 14: 457, 1978
- Meyers BR. Clinical experience with cefotaxime in the treatment of patients with bacteremia. Rev Infect Dis 4 ( Suppl): S411, 1982
- Miller MH, Wexler MA, Steigbigel NH. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis. Emergence of gentamicin-resistant mutants. Antimicrob Agents Chemother 14: 336, 1978
- Mills J, Drew D. Serratia marcescens endocarditis. A regional illness associated with intravenous drug abuse. Ann Intern Med 84: 29, 1976
- Moellering RC, Wennersten C, Weinberg AN. Synergy of penicillin and gentamicin against enterococci. J Infect Dis 124 ( Suppl): S207, 1971
- Mohr DN, Feist DJ, Washington JA II, Herman PE. Infections due to group C streptococci in man. Am J Med 66: 450, 1979
- Myers JP, Linnemann CC Jr. Bacteremia due to methicillin-resistant Staphylococcus aureus. J Infect Dis 145: 532, 1982
- Neu HC. Amoxicillin. Ann Intern Med 90: 356, 1979
- Neu HC. Carbenicillin and ticarcillin. Med Clin North Am 66: 61, 1982
- Neu HC. The efficacy of mezlocillin in the therapy of bacteremia. J Antimicrob Chemother 9 ( Suppl A): 23, 1982
- Overturf GD, Horowitz M, Wilkins J, Leedom J, Steinberg E. Bactericidal studies of penicillin-gentamicin combinations against group B streptococci. J Antibiot 30: 513, 1977
- Parker RH, Kalinske RW, Hoeprich PD. Cephaloridine therapy of endocarditis and other life-threatening infections. In: Hobby GL, ed. Antimicrobial agents and chemotherapy—1967. Ann Arbor: American Society for Microbiology 150, 1968
- Parker RH, Fossieck BE Jr. Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis. Ann Intern Med 93: 832, 1980
- Quinn EL, Pohlod D, Madhavan T, Burch K, Fisher E, Cox F. Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis. J Infect Dis 128 ( Suppl): S386, 1973
- Rajashedkaraiah KR, Riche T, Rao VS, Marsh D, Ramakrishna B, Kallick CA. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann Intern Med 93: 796, 1980
- Rahal JJ Jr, Meyers BR, Weinstein L. Treatment of bacterial endocarditis with cephalothin. N Engl J Med 279: 1305, 1968
- Reinarz JA, Kier CM, Guckian JC. Evaluation of cefazolin in the treatment of bacterial endocarditis and bacteremia. J Infect Dis 128 ( Suppl): S392, 1973
- Reyes MP, Brown WJ, Lerner AM. Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy. Medicine (Baltimore) 57: 57, 1978
- Reyes MP, Lerner AM. Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis 5: 314, 1983
- Reymann MT, Holley HP Jr, Cobbs CG. Persistent bacteremia in staphylococcal endocarditis. Am J Med 65: 729, 1978
- Roberts RB, Kreiger AG, Schiller NL, Gross KC. Viridans streptococcal endocarditis. The role of various species including pyridoxal-dependent streptococci. Rev Infect Dis 1: 955, 1979
- Salzer W, Pegram PS Jr, McCall CE. Clinical evaluation of moxalactam. Evidence of decreased efficacy in gram-positive aerobic infections. Antimicrob Agents Chemother 23: 565, 1983
- Sande MA, Courtney KB. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med 88: 118, 1978
- Savage D, Brown J. Endocarditis due to group A streptococcus. Am J Med Sci 282: 98, 1981
- Sklaver AR, Hoffman TA, Greenman RL. Staphylococcal endocarditis in addicts. South Med J 71: 638, 1978
- Straus AL, Hamburger M. Pneumococcal endocarditis in the penicillin era. Arch Intern med 118: 190, 1966
- Tan JS, Terhune CA Jr, Kaplan S, Hamburger M. Successful two week treatment schedule for penicillin susceptible Streptococcus viridans endocarditis. Lancet 2: 1340, 1971
- Tuazon CU, Cardella TA, Sheagren JN. Staphylococcal endocarditis in drug users. Clinical and microbiologic aspects. Arch Intern Med 135: 1555, 1975
- Van der Anwera P, Klastersky J. In vitro study of the combination of rifampin with oxacillin against Staphylococcus aureus. Rev Infect Dis 5 ( Suppl): S509, 1983
- Wade JC, Schimpff SC, Newman KA, Fortner CL, Standiford HC, Wiernik PH. Piperacillin or ticarcillin plus amikacin. A double blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients. Am J Med 71: 983, 1981
- Watanakunakorn C. Penicillin combined with gentamicin and streptomycin. Synergism against enterococci. J Infect Dis 124: 581, 1971
- Watanakunakorn C, Tan JS, Phair JP. Some salient features of Staphylococcus aureus endocarditis. Am J Med 54: 473, 1973
- Watanakunakorn C, Glotzbecker C. Enhancement of the effects of antistaphylococcal antibiotics by aminoglycosides. Antimicrob Agents Chemother 6: 802, 1974
- Watanakunakorn C, Baird IM. Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin. Am J Med Sci 273: 133, 1977
- Watanakunakorn C, Glotzbecker C. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilrnicin. Antimicrob Agents Chemother 12: 346, 1977
- Watanakunakorn C. Antimicrobial therapy of endocarditis due to less common bacteria. In: Bisno AL, ed. Treatment of infective endocarditis. New York: Grune and Stratton, 123, 1981
- Watanakunakorn C. Treatment of infections due to methicillin-resistant Staphylococcus aureus. Ann Intern Med 97: 376, 1982
- Watanakunakorn C, Tisone JC. Antagonism between nafcillin or oxacillin and rifampin against Staphylococcus aureus. Antimicrob Agents Chemother 22: 920, 1982
- Webb D, Thadepalli H, Bach V. Cefoxitin therapy for bacterial endocarditis. Rev Infect Dis 1: 170, 1979
- Webb D, Thadepalli H. Evaluation of cefoxitin, cefazolin and cephradine in comparison with methicillin in the treatment of bacterial endocarditis. Curr Therapeut Res 34: 311, 1983
- Wilson WR, Thompson RL, Wilkowske CJ, Washington JA, Giuliani ER, Geraci JE. Short term therapy of streptococcal infective endocarditis. JAMA 245: 360, 1981
- Wilson WR, Geraci JE. Antibiotic treatment or infective endocarditis. Ann Rev Med 34: 413, 1983
- Winston DJ, Murphy W, Young LS, Hewitt WL. Piperacillin therapy for serious bacterial infections. Am J Med 69: 255, 1980
- Winston DJ, Kurtz TO, Young LS, Busuttil RW. Moxalactam for treatment of nosocomial infection. Rev Infect Dis 4 ( Suppl 1): S650, 1982
- Wolfe JD, Johnson WD. Penicillin-sensitive streptococcal endocarditis. In vitro and clinical observations on penicillin-streptomycin therapy. Ann Intern Med 81: 178, 1974
- Zak O, Sheld MW, Sande MA. Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits. Rev Infect Dis 5 ( Suppl): S481, 1983
- Zinner SH, Lagast H, Klastersky J. Antistaphylococcal activity of rifampin with other antibiotics. J Infect Dis 144: 365, 1981
References
- Auvergant JC, Massip P, Dabernat H, Tho TV, Armengaud M. Utilisation des céphalosporines dans le traitement des méningites a germes rares. Med Mal Inf 9: 592, 1979
- Belohradsky BH, Geiss D, Marget W, Bruch K, Kafetzis D, Peters G. Intravenous cefotaxime in children with bacterial meningitis. Lancet 1: 61, 1980
- Berk SL, McCabe WR. Meningitis caused by Gram-negative bacilli. Ann Intern Med 93: 253, 1980
- Black JA. Paediatric Emergencies (Black JA, ed), p. 349. Butterworth, London, 1979
- Cefuroxime versus ampicillin and chloramphenicol for the treatment of bacterial meningitis, Report from a Swedish Study Group. Lancet I: 295, 1982
- De Los A, Del Rio M, Shelton M, Chrane D, McCracken GH Jr, Nelson JD. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet I: 1241, 1983
- Del Rio M, McCracken GH Jr, Nelson JD, Chrane D, Shelton S. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis. Antimicrob Ag Chemother 22: 622, 1982
- Dillon HD. Studies of moxalactam for Gram-negative and Haemophilus influenzae meningitis: an appraisal. J Pediatr 99: 907, 1981
- Lambert HP. Problems with neonatal meningitis. J Antimicrob Chemother 3: 381, 1977
- Landesman SH, Corrado ML, Shah PM, Armengaud M, Barza M, Cherubin CE. Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in Gram-negative bacillary meningitis. Am J Med 71: 693, 1981
- McCracken GH, Mize SG, Threlkeld N. Intraventricular gentamicin therapy in Gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Co-operative Study Group. Lancet I:787, 1980
- Modai J, Wolff M, Lebas J, Meulemans A, Manuel C. Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis. Antimicrob Ag Chemother 21: 551, 1982
- Netland A, Muller AE, Andrew E. Concentration of cefuroxime in the cerebrospinal fluid in patients with bacterial meningitis. Scand J Infect Dis 13: 273, 1981
- Olson DA, Hoeprich PD, Nolan SM, Goldstein E. Successful treatment of Gram-negative bacillary meningitis with moxalactam. Ann Intern Med 95: 302, 1981
- Rahal JJ, Simberkoff MS. Host defences and antimicrobial therapy in adult Gram-negative bacillary meningitis. Ann Intern Med 96: 468, 1982
- Rudetsky MS, Istre GR, Johansen TL, Parmelee SW, Lawer BA, Wiesenthal AM, Glode MP. Multiply resistant pneumococcus causing meningitis; its epidemiology within a day-care centre. Lancet II: 771, 1981
- Sabel KG, Brandberg Å. Treatment of meningitis and septicaemia in infancy with a sulphameth-oxazole/trimethoprim combination. Acta Paediatr Scand 64: 25, 1975
- Schaad UB, McCracken GH Jr, Threlkeld N, Thomas ML. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. J Pediatr 98: 129, 1981
- Simasathien S, Duangmani C, Echeverria P. Haemophilus influenzae type b resistant to ampicillin and chloramphenicol in an orphanage in Thailand. Lancet II: 1214, 1980
- Simberkoff MS, Moldover NH, Kahal JJ Jr. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. J Lab Clin Med 95: 362, 1980
- Uchiyama N, Greene GR, Kitts DB, Thrupp LD. Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol. J Pediatr 97: 421, 1980
References
- Branefors-Helander P, Jeppsson P-H. Acute epiglottitis. Scand J Infect Dis 7: 103, 1975
- Breese BB, Breese Hall C. Beta-hemolytic streptococcal diseases. Boston: Houghton Krifflin Professional Publishers, 1978
- Carenfelt C, Lundberg C. The role of local gas composition in pathogenesis of maxillary sinus empyema. Acta Otolaryngol 85: 116, 1978
- Carenfelt C, Lundberg C, Nord CE, Wretlind B. Bacteriology of maxillary sinusitis in relation to quality of the retained secretion. Acta Otolaryngol 86: 298, 1978
- van Cauwenberge P, Verschraegen G, Renterghem L. Bacteriological findings in sinusitis. Scand J Infect Dis 9: 72, 1976
- Dillon HC. Streptococcal infections of the skin and their complications: Impetigo and nephritis. In: Wannamaker LW, Matsen JM, eds. Streptococci and streptococcal diseases. New York: Academic Press, 1972
- Ernstsson S. Personal communication
- Flodström A, Hallander H. Microbiological aspects on peritonsillar abscesses. Scand J Infect Dis 8: 157, 1976
- Frederick J, Braude AI. Anaerobic infection of the paranasal sinuses. N Engl J Med 290: 135, 1974
- Jackson GG, Muldson RL. Viruses causing common respiratory infections in man. University of Chicago Press, 1975
- Jokipii AM, Karma P, Ojala K, Jokipii L. Anaerobic bacteria in chronic otitis media. Arch Otolaryngol 103: 278, 1977
- Kallings I, Bengtsson S, Christensen P, Holm SE, Lind L, Kalin M. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus penumoniae, Streptococcus pyogenes, and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis, Suppl. 39: 100, 1983
- Kamme C, Lundgren K, Mårdh P-A. The etiology of otitis media in children. Scand J Infect Dis 3: 217, 1971
- Klein J. Microbiology of otitis media. Ann Otol Rhinol Laryngol, Suppl. 68: 98, 1980
- Liu Y, Lang R, Lim DJ, Birch H. Microorganisms in chronic otitis media with effusion. Ann Otol Rhinol Laryngol 85, Suppl. 25: 245, 1976
- Meyer RD, Finegold SM. Anaerobic infections: Diagnosis and treatment. South Med J 69: 1178, 1976
- Schalèn M, Christensen P, Kamme C, Mörner H, Petterson K-J, Schalèn C. High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scand J Infect Dis 12: 277, 1980
- Tunér K, Nord CE. Beta-lactamase-producing microorganisms in recurrent tonsillitis. Scand J Infect Dis, Suppl. 39: 83, 1983
- Wald E, Milmoe G, Bowen A. Acute maxillary sinusitis in children. N Engl J Med 304: 749, 1981
- Wald E, Pang D, Milmoe G, Schramm V. Sinusitis and its complications in the pediatric patient. Pediatrics Clin North Am 28: 777, 1981
References
- Fekety RF, Caldwell J, Grump D, Johnsen J, Maxson W, Mulholland J, Thoburn R. Bacteria, viruses and mycoplasmas in acute pneumonia in adults. Am Rev Resp Dis 104: 499, 1971
- Fransén H. Wolontis S. Infections with viruses, Mycoplasma pneumoniae and bacteria in acute respiratory illness. Scand J Infect Dis 1: 31, 1969
- Garb JL, Brown RB, Garb JR, Tuthill RW. Differences in etiology of pneumonias in nursing homes and community patients. JAMA 240: 2169, 1978
- Johanson WG, Pierce AK, Sandford JP. Nosocomial respiratory infections with Gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 71: 701, 1972
- Matthay RA, Greene WH. Pulmonary infections in the immunocompromized patient. The Medical Clinics of North America. Philadelphia: WB Saunders, 529, 1980
- Schreiner A, Digranes A, Myking O, Solberg CO. Wert der transtrachealen Aspiration bei bronchopulmonalen Infektionen im Erwachsenenalter. Infection 1: 137, 1973
- Schreiner A, Bjerkestrand G, Digranes A, Halvorsen JF, Kommedal TM. Bacteriological findings in the aspirate from patients with acute exacerbation of chronic bronchitis. Infection 6: 54, 1978
- Tillotson JR, Lerner AM. Pneumonias caused by Gram-negative bacilli. Medicine 45: 65, 1966
- Schreiner A, Digranes A. Bacteriology of acute respiratory tract infections. J Infect 1, Suppl 2: 23, 1979
- Sullivan JR, Dowdle WR, Marine WM, Hierholzer JC. Adult pneumonia in a general hospital. Arch Intern Med 29: 935, 1972
- White RJ, Blainey AD, Harrison K, Clarke SKR. Causes of pneumonia presenting to a district hospital. Thorax 36: 566, 1981
References
- Armstrong GC, Wise R, Brown RM, Hancox J. Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations. Antimicrob Agents Chemother 20: 356, 1981
- Bach MC, Eron LJ, Goldenberg RI, Park CH, Poretz DM. Ceftazidime therapy of serious bacterial infections. Spitzy KH, Karrer K, eds. Proc 13th Int Congr Chemother, Vienna, 57: 21, 1983
- Bergan T, Versland I. The mini-pig as a model for penetrations of penicillins. Scand J Infect Dis, Suppl 14: 135, 1978
- Bergan T. Tissue pharmacokinetics of ceftriaxone. In: Spitzy KH, Karrer K, eds. Proc. 13th Int Congr Chemother, Vienna, 28: 5, 1983
- Berger SA, Barza M, Haber J, Bell D, Waintraub S, Burtyk ML, Kane A. Penetration of antibiotics into decubitus ulcers. J Antimicrob Chemother 7: 193, 1981
- Brook I, Finegold SM. Aerobic and anaerobic bacteriology of cutaneous abscesses in children. Pediatrics 67: 891, 1981
- Carbon C, Nguyen PC, Contretois A, Lamotte-Barrillon S. Tissue cage experiments with beta-lactam antibiotics in rabbits. Scand J Infect Dis, Suppl 14: 127, 1978
- Chiedozi LC. Pyomyositis: Review of 205 cases in 112 patients. Am J Surg 137: 255, 1979
- Chisholm GD. The tissue cage model in the distribution of antibacterial agents. Scand J Infect Dis, Suppl 14: 118, 1978
- Dajani AS. The scalded skin syndrome: Relationship to phage group II staphylococci. J Infect Dis 125: 548, 1972
- Dellinger EP. Severe necrotizing soft tissue infections. Multiple disease entities requiring a common approach. JAMA 246: 1717, 1981
- Draphin MS, Wilson ME, Shrager SM, Rubin RH. Bacteremic Hemophilus influenzae type B cellulitis in the adult. Am J Med 63: 449, 1977
- Finegold SM, ed. Infections of the skin, soft tissue, and muscle. In: Anaerobic bacteria in human disease. New York: Academic Press, 386, 1977
- Galpin JE, Chow AW, Byer AS, Gue LB. Sepsis associated with decubitus ulcer. Am J Med 61: 346, 1976
- Garrel JP, Sonneck JM, Thabaut A, Leauté JB. Augmentin in the treatment of skin infections. In: Croyden EAP, Michel MF, eds. Augmentin, Proc Eur Symp, Scheveningen, The Netherlands, 28–29 June, 1982. Amsterdam: Excerpta Medica 234, 1983.
- Ghoneim ATM, McGoldrick J, Blinck PWH, Flowers MW, Marsden AK, Wilson DH. Aerobic and anaerobic bacteriology of subcutaneous abscesses. Br J Surg 68: 498, 1981
- Grieco MH, Sheldon C. Erysipelothrix rhusiopathiae. Ann NY Acad Sci 174: 523, 1970
- Guiliano A, Lewis Jr F, Hadley K, Blaisdell FW. Bacteriology of necrotizing fasciitis. Am J Surg 134: 52, 1977
- Hedström SÅ. Differential diagnosis and treatment of gas-producing infections. Acta Chir Scand 141: 582, 1975
- Hedström SÅ, Kahlmeter G. Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmacokinetic evaluation. Scand J Infect Dis 12: 221, 1980
- Hedström, SÅ. Recurrent anaerobic skin infections. Scand J Infect Dis 14: 241, 1982
- Hedström, SÅ. Recurrent staphylococcal furunculosis: Treatment and prevention. Clinical and bacteriological follow-up. Scand J Infect Dis. Subm for publ 1984
- Hoffstedt B. Penetration of antibiotics into subcutaneous tissue fluid with special reference to a new modified thread sampling technique. Scand J Infect Dis, Suppl 30, 1981
- Johnson JT, Yu VL, Muder RR, Thearle PB, Diven WF, Myers EN, Schramm VL. Efficacy of cefoperazone in prophylaxis for head and neck surgery: A prospective randomized double-blind trial. In: Spitzy KH, Karrer K, eds. Proc 13th Int Congr Chemother, Vienna, 33: 10, 1983
- Kaiser RE, Cerra FB. Progressive necrotizing surgical infections. A unified approach. J Trauma 21: 349, 1981
- Kitzis MD, Juillet Y, Feissinger JN, Housset E, Acar JF. The penetration of Augmentin into ischaemic ulcers of the leg. In: Croydon EAP, Michel MF, eds. Augmentin, Proc Eur Symp, Scheveningen, The Netherlands, 28–29 June, 1982. Amsterdam: Excerpta Medica 227, 1983.
- Levin ME, O'Neal LW eds. The diabetic foot, 2nd ed. S:t Louis: Mosby, 1977
- Lidgren L, Hedström SÅ, Melin LO. Der infizierte Fuss. In: Murri A, ed. Der Fuss. Uelzen: Medizinisch-Literarische Verlagsgesellschaft mbH, 237, 1981
- Meleney FL. Hemolytic streptococcus gangrene. Arch Surg 9: 317, 1924
- Meislin HW, Lerner SA, Graves MH, McGehee MD, Kocka FE, Morello SA, Rosen P. Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management. Ann Intern Med 87: 145, 1977
- Novelli A, Mazzei T, Ciuffi M, Nicoletti P, Periti P. Cefotetan pharmacokinetics in healthy volunteers after intramuscular administration: Diffusion in milk and extra-vascular fluid. In: Spitzy KH, Karrer K, eds. Proc 13th Int Congr Chemother, Vienna, 25: 15, 1983
- Periti P. Piperacillin, a cephalosporin-like penicillin: Laboratory and clinical experience. In: Spitzy KH, Karrer K, eds. Proc 13th Int Congr Chemother, Vienna, 8: 41, 1983
- Ryan RM, Mason U, Harding SM. The penetration of ceftazidime into extravascular fluid. J Antimicr Chemother 8, Suppl B: 263, 1981
- Roding B, Groenvold PHA, Boerma I. Ten years of experience in the treatment of gas gangrene with hyperbaric oxygen. Surg Gynecol Obstet 134: 579, 1972
- Roos J, Bakker DJ. Antibiotics and hyperbaric oxygen in serious soft tissue infections. Paper read at 1st European Conference on Hyperbaric Medicine, Amsterdam, Sept 7–9, 1983
- Schreiner A, Hellum KB, Digranes A, Bergman I. Transfer of penicillin G and ampicillin into human skin blisters induced by suction. Scand J Infect Dis, Suppl 14: 233, 1978
- Scully B, Neu H. Aztreonam therapy of critically ill patients. In: Spitzy KH, Karrer K, eds. Proc 13th Int Congr Chemother, Vienna, 15: 37, 1983
- Simon C, Malerczyk V, Klaus M. Absorption of bacampicillin and ampicillin and penetration into body fluids (skin blister fluid, saliva, tears) in healthy volunteers. Scand J Infect Dis, Suppl 14: 228, 1978
- Stone HH, Martin JD Jr. Synergistic necrotizing cellulitis. Ann Surg 175: 702, 1972
- Swartz MN. Myositis. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. New York: Wiley, 818, 1979
- Tally FP, Ho JL, Gorbach SL. Thienamycin in the treatment of mixed infections. In: Spitzy KH, Karrer K, eds. Proc 13th Int Congr Chemother, Vienna, 14: 30, 1983
- Taylor JF, Shaw B, Bluming A, Briers P, Friedman E, Henderson B, Horn C, Mohan S, Pike M. Tropical myositis: Clinical and laboratory studies. Afr J Med Sci 4: 4098, 1973
- Weinberg AN, Swartz MN. Gram-negative coccal and bacillary infections. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine, 2nd ed. New York: McGraw-Hill, 1445, 1979
- Winslow DJ. Botryomycosis. Am J Path 35: 153, 1959
- Wise R, Baker S, Livingstone R. Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels. Antimicr Agents Chemother 18: 369, 1980
- Wise R, Dyas A, Hegasty A, Andrews JM. Pharmacokinetics and tissue penetration of aztreonam. Antimicrob Agent Chemother 22: 969, 1982
- Cars, O. Tissue distribution of beta-lactam antibiotics. Experimental studies in rabbit. Scand J Infect Dis Suppl 27: 4, 1981
References
- Adam D. Editorial: Blutgerinnungs-Gestöhrungen unter Breitband-Antibiotika. Diagnostik und Intensiv Ther 7: 228, 1980
- Appel GB, Neu HC. The nephrotoxicity of antibacterial agents. N Engl J Med 296: 663, 1977
- Arvidsson A, Borgå O, Kager L, Pieper R. Renal elimination of cefoxitin and effect of probenecid after single and repeated doses. J Antimicrob Chemother 7: 423, 1981
- Carlberg H, Alestig K, Nord CE, Trollfors B. Intestinal side effects of cefoperazone. J Antimicrob Chemother 10: 483, 1982
- Drusano GL, Warren JW, Saah AJ, Caplan ES, Tenney JH, Hansen S, Granados J, Standiford HC, Miller EH. A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surg Gynecol Obstet 154: 715, 1982
- Duignan JP, Power-O'Daly M, Murray T, Hone R. Comparative clinical trial of sulbactam and ampicillin with gentamicin and metronidazole in the management of severe abdominal sepsis. Proc 13th Int Congress of Chemotherapy, Vienna, 82: 6, 1983
- Evaldson G, Heimdahl A, Kager L, Nord CE. The normal human anaerobic microflora. Scand J Infect Dis Suppl 35: 4, 1982
- Le Frock JL, Molavi A, Carr B, Rolston K, Schell R, Chandrasekar P, Kamangara W. Mezlocillin versus cefoxitin in intraabdominal and pelvic infections. Proc 13th Int Congress of Chemother, Vienna, 82: 10, 1983
- Giamarellou H, Kalodiki F, Vlachos G, Trouvas D, Avlami A, Ballas P, Daikos GK. Prospective comparative evaluation of moxalactam versus tobramycin plus clindamycin in the treatment of anaerobic infections. Proc 13th International Congress of Chemotherapy, Vienna, 82: 1, 1983
- Heimdahl A, Kager L, Malmborg AS, Nord CE. Impact of different betalactam antibiotics on the normal human flora, and colonization of the oral cavity, throat and colon. Infection 10: 120, 1982
- Hoffman CEJ, McDonald PJ, Watts J. Use of peroperative cefoxitin to prevent infection after colonic and rectal surgery. Ann Surg 193: 353, 1981
- Kager L, Ljungdahl I, Malmborg AS, Nord CE, Pieper R, Dahlgren P. Antibiotic prophylaxis with cefoxitin in colorectal surgery. Effect on the colon microflora and septic complications. A clinical model for prediction of the benefit and risks in using a new antibiotic in prophylaxis. Ann Surg 193: 277, 1981
- Kager L, Malmborg AS, Nord CE, Pieper R. The effect of short-term cefoxitin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Infection 10: 338, 1982
- Kager L, Liljeqvist L, Malmborg AS, Nord CE, Pieper R. Effects of ampicillin plus sulbactam on bowel flora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 22: 208, 1982
- Kager L, Malmborg AS, Nord CE, Sjöstedt S. The effect of piperacillin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Infection 11: 251, 1983
- Kager L, Malmborg AS, Sjöstedt S, Nord CE. Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery. Eur J Clin Microbiol 2: 559, 1983
- Kager L, Malmborg AS, Nord CE. Impact of short-term as compared with long-term prophylaxis with cefoxitin on the colonic microflora in patients undergoing colorectal surgery. Drugs Exptl Clin Res 9: 387, 1983
- Kager L, Malmborg AS, Nord CE, Sjöstedt S. Impact of a single dose as compared to three doses prophylaxis with moxalactam on the colonic microflora in patients undergoing colorectal surgery. J Antimicrob Chemother, in press, 1984
- Kennedy RH, Allan PM, Skandall AA, Johnson CD, Harrison J, Morrisey S, Allan A. A prospective, randomized trial to compare the efficacy of piperacillin against a standard combination of drugs in the treatment of serious intraabdominal sepsis. Proc 13th Int Congress of Chemother, Vienna, 82: 30, 1983
- Nichols RL. Infections following gastrointestinal surgery: Intraabdominal abscess. Surg Clin North Am 60: 197, 1980
- Nichols RL, Smith JW, Trunkey DD, Mills J. Clindamycin-gentamicin versus cefoxitin for traumatic fecal soilage of the peritoneum. Abstract no 103. 21st Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Washington D.C. 1981
- Nord CE, Kager L, Philipson A, Stiernstedt G. Impact of imipenem/cilastatin therapy on faecal flora. Eur J Clin Microbiol. In press, 1984
- Norrby R, Friberg K, Holm S. In vitro antibacterial activity of SQ 26,776. J Antimicrob Chemother 8, suppl F: 69, 1981
- Rambo WM, del Bene VE, Burkey LG, Collins CD, Richmond DK. Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections. Rev Inf Dis 4: 683, 1982
- The Scandinavian study group of imipenem. Imipenem/cilastatin versus gentamicin/clindamycin for the treatment of serious bacterial infections. Lancet. 1: 868, 1984
- Schentag JJ, Wels PB, Reitberg DP, Walczak P, Hawkins van Tyle J, Lascola RJ. A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis. Ann Surg 198: 35, 1983
- Schentag JJ, Wels PB, Simons GW, Swabb EA, Vigano A, Reiberg DP, Smith IL, Swanson DJ, Lascola RJ, Walszak P, Ryan T. Abdominal fluid penetration of aztreonam versus tobramycin in patients with abdominal sepsis. Proc 13th Int Congress of Chemother, Vienna 27: 27, 1983
- Sjöstedt S, Heimdahl A, Kager L, Nord CE. Microbial colonization of the oropharynx, esophagus and stomach in patients with gastric diseases. Euro J Clin Microbiol. In press, 1984
- Stone HH, Strom PR, Fabian TC, Dunlop WE. Third generation cephalosporins for polymicrobial surgical sepsis. Arch Surg 118: 193, 1983
- Tally FP, McGowan K, Kellum JM, Gorbach SL, O'Donnel TF. A randomized comparison of cefoxitin with and without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg 193: 318, 1981
- Thadepalli H, Gorbach SL, Broido PW, Norsen J, Nyhus L. Abdominal trauma, anaerobes, and antibiotics. Surg Gynecol Obstet 137: 270, 1973
- Wise R, Donovan IA, Andrews JM, Drumm J, Bennett S. Penetration of sulbactam and ampicillin into peritoneal fluid. Antimicrob Agents Chemother 2: 290, 1983
- van der Waaij D. Colonization resistance of the digestive tract: Clinical consequences and implications. J Antimicrob Agents Chemother 10: 263, 1982
- Wittman DH, Schassan HH. Distribution of moxalactam in serum, bone, tissue fluid and peritoneal fluid. Rev Inf Dis 4: 610, 1982
- Wittman DH, Schassan HH. Penetration of eight beta-lactam antibiotics into the peritoneal fluid. Arch Surg 118: 205, 1983
- Yellin AE, Berne TV, Heseltine PNR, Appleman MD. The effectiveness of ampicillin-sulbactam in surgically treated gangrenous or perforated appendicitis. Proc 13th Int Congress of Chemother, Vienna, 23: 34, 1983
- Yu VL. Enterococcal superinfection and colonization after therapy with moxalactam. A new broad spectrum antibiotics. Ann Intern Med 94: 784, 1981
References
- Aswapokee N, Aswapokee P, Fu KP, Neu HC. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins. Antimicrob Agents Chemother 14: 1, 1978
- Fang LST, Tolkoff-Rubin NE, Rubin RH. Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection, localized by the antibody-coated bacteria technic. N Engl J Med 298: 413, 1978
- Giamarellou H, Avlami A, Matsakas V, Kosmidis J, Daikos GK. In vitro studies with ceftazidime. J Antimicrob Chemother 8, Suppl. B: 73, 1981
- Kosmidis J, Anyfantis A, Stathakis C, Mantopoulos K, Daikos GK. Augmentin (amoxicillin plus sodium clavulanate, a beta-lactamase inhibitor) is active in amoxicillin-resistant infections. In: Nelson JD, Grassi C, eds. Current chemotherapy and infectious disease. Washington DC: American Society for Microbiology, 330, 1980
- Lee FH, Pfeffer M, Van Harken DR, Smyth RD, Hottendorf GH. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans. Antimicrob Agents Chemother 17: 188, 1980
- Paisley JW, Washington II JA. Combined activity of clavulanic acid and ticarcillin against ticarcillin-resistant, Gram-negative bacilli. Antimicrob Agents Chemother 14: 224, 1978
- Slocombe B, Basker MJ, Bentley PH, Clayton JP, Cole M, Comber KR, Dixon RA, Edmonson RA, Jackson D, Merrikin DJ, Sutherland R. BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans. Antimicrob Agents Chemother 20: 38, 1981
References
- Adam D, Reichart B, Williams KJ. Penetration of ceftazidime into human tissue in patients undergoing cardiac surgery. J Antimicrob Chemother 12 ( Suppl A): 269, 1983
- Adeyokunnu AA, Hendrickse RG. Salmonella osteomyelitis in childhood. Arch Dis Child 55: 175, 1980
- Ancona RJ, McAuliffe J, Thompson TR, Speert DP, Ferrieri P. Group B streptococcal sepsis with osteomyelitis and arthritis. Am J Dis Child 133: 919, 1979
- Anderson JR, Scobie WG, Watt B. The treatment of acute osteomyelitis in children: A 10 year perspective. J Antimicrob Chemother 7 ( Suppl A): 43, 1981
- Anonymous editorial. Some problems of acute osteomyelitis. Br Med J 4: 317, 1972
- Anonymous editorial. Salmonella bone and joint infections. J Infect 6: 107, 1983
- Antoniskis A, Anderson BC, Van Volinburg EJ, Jackson JM, Gilbert DN. Feasibility of outpatient self-administration of parenteral antibiotics. West J Med 128: 203, 1978
- Arango JL, Trujillo H, Worren D, Uribe A, Aquedelo N, deVidal EL. Effectiveness of two new cephalosporins, cephazolin and cephapirin, administered intermittently in acute and chronic osteomyelitis in children. J Int Med Res 4: 183, 1976
- Ashby ME. Serratia osteomyelitis in heroin users. J Bone Joint Surg (AM) 58: 132, 1976
- Barry AL, Thornsberry C, Jones RN, Gerlach EH. In vitro evaluation of LY127935 (6059-S) in comparison with 11 related beta-lactam compounds and two aminoglycosides. In: Nelson JD, Grassi C, eds. Current chemotherapy and infectious diseases. Washington: ASM, 76, 1980
- Bristol-Myers, data on file
- Bell S. Further observations on the value of oral penicillins in chronic staphylococcal osteomyelitis. Med J Aust 2: 591, 1976
- Bergdahl S, Elinder G, Eriksson M. Treatment of neonatal osteomyelitis with cloxacillin in combination with fusidic acid. Scand J Infect Dis 13: 281, 1981
- Bernstein BM, Fass RJ. Treatment of osteomyelitis and septic arthritis with cefamandole. Am J Med Sci 284: 2, 1982
- Bjorkholm B, Eilad T. Pasteurella multocida osteomyelitis caused by cat bite. J Infect 6: 175, 1983
- Brand RA, Black H. Pseudomonas osteomyelitis following puncture wounds in children. J Bone Joint Surg (Am) 56: 1637, 1974
- Bryson YJ, Connor JD, LeClerc M, Giammona ST. High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children. J Pediatr 94: 673, 1979
- Cafferkey MT, Hone R, Keane CT. Severe staphylococcal infections treated with vancomycin. J Antimicrob Chemother 9: 69, 1982
- Cafferkey MT, Luke DS, Keane CT. Sternal and costochondral infections with gentamicin and methicillin resistant Staphylococcus aureus following thoracic surgery. Scand J Infect Dis 15: 267, 1983
- Canale ST, Manugian AH. Neonatal osteomyelitis of the os calcis: A complication of repeated heel punctures. Clin Orthop 156: 178, 1981
- Castleman B. Case records of the Massachusetts General Hospital. N Engl J Med 285: 166, 1971
- Chisolm DR, Leitner F, Misiek M, Wright GE, Price KE. Laboratory studies with a new cephalosporanic acid derivative. Antimicrob Agents Chemother 1969: 244, 1970
- Cimarusti CM, Sykes RB, Applegate HA, Bonner DP, Breuer H, Chang HW, Denzel Th, Floyd DM, Fritz AW, Koster WC, Liu WC, Parker WL, Rathnum ML, Slusarchyk WA, Treuner UD, Young MG. Monobactams (Monocyclic beta-lactam antibiotics derived from bacteria). The derivation of SQ26 776. In: Neu HC ed. New beta-lactam antibiotics: a review from chemistry to clinical efficacy of the new cephalosporins. Philadelphia: Francis Clark Wood Institute for the History of Medicine, College of Physicians of Philadelphia, 35, 1982
- Cohen JI. Drug resistant osteomyelitis in a diabetic patient. Johns Hopkins Med J 146: 171, 1980
- Colville J, Regan BF, Brady PG. Acute haemotagenous osteomyelitis in children with emphasis on treatment. J Irish Med Assoc 69: 200, 1976
- DasDe S, McAllister TA. Pseudomonas osteomyelitis following puncture wounds of the foot in children. Injury 12: 336, 1981
- DeGroote W, Van Dooren J, Verdonk R, Uyttendaele D, Vercauteren M, Claessens H. The use of gentamycin-PMMA (polymethylmethacrylate) beads in the treatment of osteomyelitis. Acta Orthopaedica Belgica 45: 125, 1979
- Dich VQ, Nelson JD, Haltalin KC. Osteomyelitis in infants and children. Am J Dis Child 129: 1273, 1975
- Dunkle LM, Brook N. Long-term follow-up of ambulatory management of osteomyelitis. Clin Pediatr 21: 650, 1982
- Dutoy JP, Wauters G. The treatment of bone infections with ceftazidime. J Antimicrob Chemother 12 ( Suppl A): 229, 1983
- Ebong WW. The treatment of severely ill patients with sickle cell anemia and associated septic arthritis. Clin Orthop 149: 145, 1980
- Edwards MS, Baker CJ, Wagner ML, Taber LH, Barrett FF. An etiologic shift in infantile osteomyelitis: The emergence of the group B streptococcus. J Pediatr 93: 578. 1978
- Ewing R, Fainstein V, Musher DM, Lidsky M, Clarridge J. Articular and skeletal infections caused by Pasteurella multocida. South Med J 73: 1349, 1980
- File data. Bristol-Myers Co
- Feigin RD, Pickering LK, Anderson D, Keeney RE, Shackleford PG. Clindamycin treatment of osteomyelitis and septic arthritis in children. Pediatr 55: 213, 1975
- Fitzgerald RH Jr, Thompson RL. Cephalosporin antibiotics in the prevention and treatment of musculoskeletal sepsis. J Bone Joint Surg (AM) 65: 1201, 1983
- Fox L, Sprunt K. Neonatal osteomyelitis. Pediatr 62: 535, 1978
- Gantz NM, McCormack WM, Laughlin LW, Shauffer IA, Cohen AS. Gonococcal osteomyelitis. An unusual complication of gonococcal arthritis. JAMA 236: 2431, 1976
- Geddes AM, StJ Dwyer N, Ball AP, Amos RS. Clindamycin in bone and joint infection. J Antimicrob Chemother 3: 501, 1977
- Gerszten E, Allison MJ, Dalton HP. An epidemiologic study of 100 consecutive cases of osteomyelitis. South Med J 63: 365, 1970
- Gilbert VE. Treatment of acute staphylococcal endocarditis, bacteremia and osteomyelitis with parenteral lincomycin and rifampin. Clin Res 31: 879 A. 1093
- Givner LB, Luddy RE, Schwartz AD. Etiology of osteomyelitis in patients with major sickle hemoglominopathies. J Pediatr 99: 411, 1981
- Glover SC, Geddes AM. Treatment of pyogenic osteomyelitis. J Antimicrob Chemother 8: 347, 1981
- Goforth WP, Karlin JM, Scurran BL, Silvani SH. Hematogenous osteomyelitis of the fifth metatarsal. J AM Pediatry Assoc 72: 285, 1982
- Goldstein EJC, Ahonhkai VI, Cristofaro RL, Pringle GF, Sierra MF. Source of Pseudomonas in osteomyelitis of heels. J Clin Microbiol 12: 711, 1980
- Granoff DM, Sargent E, Jolivette D. Haemophilus influenzae type B osteomyelitis. Am J Dis child 132: 488, 1978
- Grieco MH. Pseudomonas arthritis and osteomyelitis. J Bone Joint Surg (AM) 54: 1693, 1972
- Gruneberg RN, Emmerson AM. Failure to prevent emergence of bacterial resistance by combination of two antibiotics fusidic acid and rifampin. J Antimicrob Chemother 6: 562, 1980
- Gutman L. Osteomyelitis and pyogenic arthritis. In: Krugman S, Katz SL, eds. Infectious diseases of children. St. Louis: CV Mosby, 220, 1981
- Hedstrom SA. The prognosis of chronic staphylococcal osteomyelitis. Scand J Infect Dis 6: 38, 1974
- Hedstrom SA. Treatment of chronic staphylococcal osteomyelitis with cloxacillin and dicloxacillin: A comparative study in 12 patients. Scand J Infect Dis 7: 55, 1975
- Hedstrom SA, Lidgren L, Torholm C, Onnerfalt R. Antibiotic containing bone cement beads in the treatment of deep muscle and skeletal infections. Acute Orthop Scan 51: 863, 1980
- Howard JB, Highgenboten CL, Nelson JD. Residual effects of septic arthritis in infancy and childhood. JAMA 236: 932, 1976
- Hughes SPF, Nixon J, Dash CH. Cephalexin in chronic osteomyelitis. J Royal Coll Surg Edinb (Scotland) 26: 335, 1981
- Hutto JH, Ayoub EM. Streptococcal osteomyelitis and arthritis in a neonate. Am J Dis child 129: 1449, 1975
- Jacobs JC. Acute osteomyelitis: Medical management in children. NY State J Med 78: 910, 1978
- Jarvis WR, Banko S, Snyder E, Baltimore RS. Pasteurella multocida osteomyelitis following dog bites. Am J Dis Child 135: 625, 1981
- Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM. Ceftazidime, a Pseudomonas active cephalosporin: in vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests. J Antimicrob Chemother 8 ( Suppl B): 187, 1981
- Kaplan SL, Mason EO, Feigin RD. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. South Med J 75: 138, 1982
- Kelly PJ, Fitzgerald RH. Bacterial arthritis. In: Braude AL, Davis CE, Fierer J, eds. Medical microbiology and infectious diseases. Philadelphia: WB Saunders, 1747, 1981
- Kolyvas E, Ahronheim G, Marks MI, Gledhill R, Owen H, Rosenthall L. Oral therapy of skeletal infections in children. Pediatr 65: 867, 1980
- Kucers A, Bennet N McK. The use of antibiotics. Philadelphia: JP Lippincott, 642, 1979
- Kurlandsky LE, Quinn PH, Sills EM. Haemophilus influenzae as a cause of Brodie's abscess in an infant. Johns Hopkins Med J 144: 15, 1979
- Landesman SH, Sreedhar PR, Ahonkhai VI. Infections in children with sickle cell anemia. Am J Pediatr Hematol Oncol 4: 407, 1982
- LeFrock JL, Paparone P, Kowalsky SF, Schell RF, Jacobs RL, Writh CR, Tillotson JR. Use of cefamandole in the treatment of soft tissue and skeletal infections. Drug Intell Clin Pharm 15: 951, 1981
- LeFrock J., Carr BB. Clinical experience with cefotaxime in the treatment of serious bone and joint infections. Rev Infect Dis 4 ( Suppl): S465, 1982
- Leonard A, Comty CM, Shapiro FL, Leopoldo R. Osteomyelitis in hemodialysis patients. Ann Intern Med 78: 651, 1973
- Levine LR, McCain E. Clinical experience with cefamandole for treatment of serious bone and joint infections. J Infect Dis 137 ( Suppl): S119, 1978
- Lewis RP, Sutter VL, Finegold SM. Bone infections involving anaerobic bacteria. Medicine 57: 279, 1978
- Light RW, Dunham TR. Vertebral osteomyelitis due to pseudomonas in the occasional heroin user. JAMA 228: 1272. 1974
- Lilien LD, Harris VJ, Ramamurthy RS, Pildes RS. Neonatal osteomyelitis of the calcaneus: Complication of heel puncture. J Pediatr 88: 478, 1976
- Liu C, Hinthorn DR. Osteomyelitis treated with cefoxitin sodium. J Antimicrob Chemother 4 ( Suppl B): 235, 1978
- Lorian V ed. Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins, 635, 1980
- Lynch MC, Dorgan JC. A case of Pseudomonas aeruginosa osteomyelitis of the tarsal cuboid following a penetration wound of the foot in childhoods. Injury 14: 354, 1983
- Mackenjee MKR, Coovadia HM, Naidoo LS. Salmonella osteomyelitis. S A Fr Med J 48: 591, 1974
- Mackey D, Varlet A, Debeaumont D. Antibiotic loaded Plaster of Paris pellets. Clin Orthop 167: 263, 1982
- MacKinnon AE. Pseudomonas osteomyelitis following puncture wounds. Postgrad Med J 51: 33, 1975
- Mackowiak PA, Jones SR, Smith JW. Diagnostic value of sinus tract cultures in chronic osteomyelitis. JAMA 239: 2772, 1978
- Mandal SP, Mandal A. Subacute salmonella osteomyelitis. J Indian Med Assoc 73: 65, 1979
- Mandell GL, Moorman DR. Treatment of experimental staphylococcal infections: Effect of rifampin alone and in combination on development of rifampin resistance. Antimicrob Agents Chemother 17: 658, 1980
- Mandell GL, Sande MA. Antimicrobial agents. Penicillins and cephalosporins. In: Gilman AG, Goodman LS, Gilman A, eds. The pharmacologic basic of therapeutics. New York: Macmillan, 1126, 1980
- Mader JT, Reinarz JA, LeFrock JL. Cefotaxime treatment in patients with osteomyelitis and septic arthritis: A multicenter study. Clin Ther 5 ( Suppl A): 10, 1982
- Mader JT, Shannon CR, Cierny G III, Reinarz JA. Treatment of acute and chronic osteomyelitis with ceftizoxime. J Antimicrob Chemother 10 ( Suppl C): 265, 1982
- Mader JT, LeFrock JL, Hyams KC, Abdolgadher M, Reinarz JA. Cefotaxime therapy for patients with osteomyelitis and septic arthritis. Rev Infect Dis 4 ( Suppl): S472, 1982
- McGuire T, Gerjarusak P, Hinthorn DR, Lui C. Osteomyelitis caused by beta hemolytic streptococcus group B. JAMA 238: 2054, 1977
- McKee KT. Osteomyelitis due to group B streptococcus in a diabetic adolescent. J Pediatr 92: 677, 1978
- Memon IA, Jacobs NM, Yeh TF, Lilien LD. Group B streptococcal osteomyelitis and septic arthritis. Am J Dis Child 133: 921, 1979
- Michelinakis E. Treatment of chronic osteomyelitis with the continuous irrigation-suction method. Acta Orthop Scand 43: 25, 1972
- Miller EH, Semian DW. Gram-negative osteomyelitis following puncture wounds of the foot. J Bone Joint Surg (AM) 57: 5375, 1975
- Miro JM, Gatell JM, Moreno MA, Mensa J, Mana J, Jimenez de Anta MT, Garcia San Miguel J. Osteomyelitis hematogena y artritis septica en drogadictos. Med Clin (Barc) 80: 232, 1983
- Moxley GF, Moffatt TL, Falls WF. Hemodialysis-related osteomyelitis. South Med J 73: 376, 1980
- Mullany LD, French MA, Nightingale CH, Low HBC, Ellison LH, Quintiliani R. Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum and intercostal muscle of patients undergoing open heart surgery. Antimicrob Agents Chemother 21: 416, 1982
- Musher DM, Fletcher T. Tolerant Staphylococcus aureus causing vertebral osteomyelitis. Arch Intern Med 142: 632, 1982
- Nade S, Robertson FW, Taylor TKF. Antibiotics in the treatment of acute osteomyelitis and acute septic arthritis in children. Med J Aust 2: 703, 1974
- Nade S. Choice of antibiotics in management of acute osteomyelitis and acute septic arthritis in children. Arch Dis Child 52: 679, 1977
- Naveh Y, Friedman A. Combined rifampicin and chloramphenicol therapy of Enterobacteria osteomyelitis. Postgrad Med J 55: 739, 1979
- Nelson JD, Koontz WC. Septic arthritis in infants and children: A review of 117 cases. Pediatr 38: 966, 1966
- Nelson JB. Antibiotic concentrations in septic joint effusions. N Engl J Med 284: 349, 1971
- Nelson JB. The bacterial etiology and antibiotic management of septic arthritis in infants and children. Pediatr 50: 437, 1972
- Nelson JB, Bucholz RW, Kusmiesz H, Shelton S. Benefits and risks of sequential parenteral-oral cephalosporin therapy for suppurative bone and joint infections. J Pediatr Orthop 2: 255, 1982
- Nelson JB, Howard JB, Shelton S. Oral antibiotic therapy for skeletal infections of children I. Antibiotic concentrations in suppurative synovial fluid. J Pediatr 92: 131, 1978
- Nicholls A, Edward N, Catto GRD. Staphylococcal septicaemia, endocarditis and osteomyelitis in dialysis and renal transplant patients. Postgrad Med J 56: 642, 1980
- Norden CW. Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin and cephalothin. J Infect Dis 132: 493, 1975
- Norden CW. Experimental osteomyelitis V. Therapeutic trials with oxacillin and sisomicin alone and in combination. J Infect Dis 137: 155, 1978
- Norden CW, Keleti E. Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination. Antimicrob Agents Chemother 17: 591, 1980
- Ortiz-Neu C, Marr JS, Cherubin CE, Neu HC. Bone and joint infections due to Salmonella. J Infect Dis 138: 820, 1978
- Overturf GD, Balfour G. Osteomyelitis and sepsis: Severe complications of fetal monitoring. Pediatr 55: 244, 1975
- Patal SA, Suleman SK. Treatment of chronic and subacute infections of bone by means of continuous instillation of rifamycin SV East. Afr Med J 52: 396, 1975
- Pichichero ME, Friesen HA. Polymicrobial osteomyelitis: Report of three cases and review of the literature. Rev Infect Dis 4: 86, 1982
- Prober CG, Yeager AS. Use of the serum bactericidal titre to assess the adequacy of oral antibiotic therapy in the treatment of acute hematogenous osteomyelitis. J Pediatr 95: 131, 1979
- Pontifex AH, McNaught DR. The treatment of chronic osteomyelitis with clindamycin. CMA Journal 109: 105, 1973
- Ragnhildstveit E, Ose L. Neonatal osteomyelitis caused by group B streptococci. Scand J Infect Dis 8: 219, 1976
- Roca RP, Yoshikawa TT. Primary skeletal infections in heroin users: A clinical characterization, diagnosis and therapy. Clin Orthop 144: 238, 1979
- Rodriquez W, Ross S, Khan W, McKay D, Moskowitz P. Clindamycin in the treatment of osteomyelitis in children. Am J Dis Child 131: 1088, 1977
- Sapico FL, Montgomerie JZ. Pyogenic vertebral osteomyelitis: Report of nine cases and review of the literature. Rev Infect Dis 1: 754, 1979
- Sapico FL, Mongomerie JZ. Vertebral osteomyelitis in intravenous drug abusers: Report of three cases and review of the literature. Rev Infect Dis 2: 196, 1980
- Schwartz RH, Reing CM. Acute hematogenous osteomyelitis secondary to Haemophilus influenzae. J Pediatr Orthop 1: 385, 1982
- Schwob MF, Jimenez-Shehab M. Cefadroxil in the treatment of osteomyelitis in children. J Int Med Res 8 ( suppl): 106, 1980
- Seeler RA, Reddi CU, Kittams D. Diplococcus pneumoniae osteomyelitis in an infant with sickle cell anemia. Clin Pediatr 13: 372, 1976
- Seeler RA, Jacobs NM. Pyogenic infections in children with sickle hemoglobinopathy. J Pediatr 90: 161, 1977
- Shah I, Kumar KS, Lerner AM. Agranulocytosis associated with chronic oral administration of cloxacillin for suppression of staphylococcal osteomyelitis. Am J Hematol 12: 203, 1982
- Shah M, Watanakunakorn C. Staphylococcus aureus sternal osteomyelitis complicating bone marrow aspiration. South Med J 71: 348, 1978
- Siebert WT, Dewan S, Williams TN Jr. Pseudomonas puncture wound osteomyelitis in adults. Am J Med Sci 283: 83, 1982
- Simons PS. Staphylococcal osteomyelitis and persistent eosinophilia in an infant. Clin Pediatr 16: 371, 1977
- Siskind B, Galliguez P, Wald ER. Group B beta hemolytic streptococcal osteomyelitis/purulent arthritis in neonates: Report of three cases. J Pediatr 87: 659, 1975
- Smith BR, Rolston KV, LeFrock JL, Bayliff C. Bone penetration of antibiotics. Orthopedics 6: 187, 1983
- Solberg CO, Schreiner A, Digranes A. Cephalexin therapy of lower respiratory tract, soft tissue and bone infections. Scand J Infect Dis 4: 241, 1972
- Steigbigel RT, Greenman RL, Remington JS. Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection. J Infect Dis 131: 245, 1975
- Stevens DL, Haburchak DR, McNitt TR, Everett ED. Group B streptococcal osteomyelitis in adults. South Med J 71: 1450, 1978
- Sutherland R, Croydon EAP, Rolinson GN. Flucloxacillin, a new isoxazolyl penicillin compared with oxacillin, cloxacillin, dicloxacillin. Br Med J 4: 455, 1970
- Svensson R, Seeberg S. Clinical evaluation of parenteral cephalexin sodium. Scand J Infect Dis 6: 279, 1974
- Tetzlaff TR, Howard JB, McCracken GH Jr, Calderon E, Larrondo J. Antibiotic concentrations in pus and bone of children with osteomyelitis. J Pediatr 92: 135, 1978
- Tetzlaff TR, McCracken GH Jr, Nelson JD. Oral antibiotic therapy for skeletal infections of children II. Therapy of osteomyelitis and suppurative arthritis. J Pediatr 92: 485, 1978
- Trujillo SH, Alvarez MR, Rodriguez BA, Roldan FR, Warren SD, Gil LH, Uribe PA, Angueldo ON. Rifampin and penicillins in the treatment of haematogenous osteomyelitis in children (In Spanish). Antioquia Med 24: 443, 1974
- Yourassowsky E, VanDerlinden MP, Lismont MJ, Crokaert F. Combination of minocycline and rifampin against methicillin and gentamicin resistant Staphylococcus aureus. J Clin Pathol 34: 559, 1981
- Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 282: 198–206, 260–266, 316–322, 1970
- Waldvogel FA, Vasey H. Osteomyelitis: The past decade. N Engl J Med 303: 360, 1980
- Waldvogel FA. Treatment of osteomyelitis and septic arthritis. Bull NY Acad Med 58: 733, 1982
- Watanakunakorn C, Glotzbecker C. Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides. Antimicrob Agents Chemother 6: 802, 1974
- Watanakunakorn C. Vertebral osteomyelitis as a complication of Pseudomonas aeruginosa pneumonia. South Med J 68: 173, 1975
- Watanakunakorn C, Guerriero JC. Interaction between vancomycin and rifampin against Staphylococcus aureus. Antimicrob Agents Chemother 19: 1089, 1981
- Weeks JL, Garcia-Prats JA, Baker CJ. Methicillin-resistant Staphylococcus aureus osteomyelitis in a neonate. JAMA 245: 1662, 1981
- Weinstein AJ. Osteomyelitis. Microbiologic, clinical, and therapeutic considerations. Primary Care 8: 557, 1981
References
- Azimi PH, Chase PA. The role of cefamandole in the treatment of Haemophilus influenzae infections in infants and children. J Pediatr 98: 995, 1980
- Baum ML, Anish DS, Chalmers TC, Sacks HS, Smith H Jr, Fagerstrom RM. A survey of clinical trials of antibiotic prophylaxis in colon surgery: Evidence against further use of no-treatment controls. N Engl J Med 305: 795, 1981
- Carlberg H, Alestig A, Nord CE, Trollfors B. Intestinal side effects of cefoperazone. J Antimicrob Chemother 10: 483, 1982
- Chalmers TC, Celano P, Sacks HS, Smith H Jr. Bias in treatment assignment in controlled clinical trials. N Engl J Med 309: 1358, 1983
- Chartrand SA, Marks MI, Roberts R, Jubilever DP, Plunkett DC. Development of Haemophilus influenzae meningitis in patients treated with cefamandole. J Pediatr 98: 1003, 1980
- The EORTC International Therapy Project Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137: 14, 1978
- Fisher LS, Chow AW, Yoshikawa TT, Guze LB. Cephalothin and cephaloridine therapy for bacterial meningitis. Ann Intern Med 86: 689, 1975
- Freiman JA, Chalmers TC, Smith H Jr, Keubler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. N Engl J Med 299: 690, 1978
- Gorbach SL, Thadepalli H, Norsen J. Anaerobic microorganisms in intraabdominal infections. In: Balows A, Dehann RM, Dowell VR, Guze LB, eds. Anaerobic bacteria: Role in disease Springfield, Ill., 399–407, 1974
- Gore SM. Assessing clinical trials—trial size. Br Med J 1: 1687, 1981
- Gore SM. Assessing clinical trials—design I. Br Med J 1: 1780, 1981
- Haines SJ, Goodman ML. Antibiotic prophylaxis of postoperative neurosurgical wound infections. J Neurosurg 56: 103, 1982
- Ishigami J, Mita T, Tanikaze S, Miyazaki S, Ono S, Kajino K, Kaneda K, Ohnishi M, Akita Y, Kuroda M, Horooka K, Kuroda K, Hineno T, Seumitso H, Tomioka S, Ohno S, Hara S, Terasoma K, Hikosaka K, Saito H, Hayashi N, Moriwaki H, Kobayashi M, Kataoka N, Uga S. Clinical evaluation of pivmecillinam in acute simple cystitis: A comparative study with amoxycillin by a randomized double-blind technique. Chemotherapy (Tokyo) 25: 337, 1977
- Kahlmeter G, Hallberg T, Kamme C. Gentamicin and tobramycin in patients with various types of infections—nephrotoxicity. J Antimicrob Chemother 4 ( Suppl. A): 47, 1978
- Lau WK, Young LS, Black RE, Winston DJ, Linné SR, Weinstein RJ, Lewitt WL. Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients. A randomized prospective trial. Am J Med 62: 959, 1977
- Love LJ, Schimpff SC, Hahn DM, Young VM, Standiford HC, Bender JF, Fortner CL, Wiernik PH. Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer. Am J Med 66: 603, 1979
- Neu HC. What do β-lactamases mean for clinical efficacy? Infection 11 ( Suppl. 2): 74, 1983
- Panwalker AP, Rosenfeld JI. Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam. J Infect Dis 141: 171, 1983
- Sanders CC, Moellering RCJ, Martin RR, Perkins RL, Strike DG, Gootz TD, Sanders WE Jr. Resistance to cefamandole: A collaborative study of emerging clinical problems. J Infect Dis 145: 118, 1982
- Stille W. The prognostic value of the antibiogram. Infection 11 ( Suppl. 2): 66, 1983
- Sylvester RJ, Pinedo HM, de Pauw M, Staquet MJ, Buyse ME, Renard J, Bonadonna G. Quality of institutional participation in multicenter clinical trials. N Engl J Med 305: 852, 1981
- Wilson P, Leung T, Williams JD. Antibacterial activity, pharmacokinetics and efficacy of cefoxitin in patients with abdominal sepsis and other infections. J Antimicrob Chemother 4 ( Suppl. B): 127, 1978